Abstract
This chart is an update to the 2014 article published in Hospital Pharmacy on injectable drugs that require protection from light. To update the chart, an online search of the FDALabel database was performed from inception through July 31, 2022 using the terms “protect” OR “light.” After filtering out drugs with non-injectable routes of administration, the list of generic drug names was combined with the 2014 list and duplicates were removed. The resulting list of drugs was then reviewed to determine whether the drugs require protection from light during storage, preparation, or administration. The reader should always consult the Food and Drug Administration-approved prescribing information for the most up-to-date information regarding the need for protection from light.
Keywords: dispensing, drug information, medication process
Introduction
Exposure to light is a concern with numerous medications due to the potential for photodegradation or other chemical reactions that affect drug stability. The purpose of this table is to update the list of injectable drugs that require protection from light that was previously published in Hospital Pharmacy in 2014. 1
A list of injectable medications that potentially required light protection was generated utilizing the online FDALabel database. 2 An advanced search of the database was conducted in October 2021. Specific details of the search included a labeling type of “human prescription drug,” an application type of New Drug Application or Biologic License Application, and the search terms “protect” OR “light.” The spreadsheet generated from this request was then reviewed to eliminate drug products with non-injectable routes of administration (eg, oral). The final list of generic drug names was then combined with the list of drugs included in the 2014 publication and duplicate entries were removed. For drug classes that appeared to have several medications requiring light protection, monographs for the entire class were checked. A supplementary search was performed in early August 2022 to ensure inclusion of newly approved injectable medications through July 31, 2022. Products that were not approved by the Food and Drug Administration were not considered further.
The most recent prescribing information (PI) was used as the primary resource for each injectable medication (confirmed as the most recent in July 2022). Additional resources were used to support information from the PI.3,4 For medications with multiple manufacturers and/or brand names, all brand name PIs were checked as well as the most recent generic PI. At least one PI was reviewed for all injectable formulations listed in the Drugs@FDA database for an individual drug. 5 When it was found that not all manufacturers specified the need for light protection, this was noted in the additional comments field and only the brand names of products requiring light protection were listed with the generic name in the first column of the table. When information was not available or consistent among these resources, additional sources were checked, a literature search was performed, and/or the manufacturer was contacted. All sources that were used are referenced accordingly. Despite efforts to confirm the information in at least 2 additional sources, some medications have the PI as the only source with instructions for light protection. When stability depends on light protection during storage, reconstitution, dilution, and/or administration, the reader should consult the references listed in the additional comments field for further details. Additional storage requirements (eg, temperature, humidity) and stability limits are not included in this table. The wording used by each manufacturer is maintained in the table as much as possible.
Although every effort has been made to ensure the accuracy and completeness of the information presented in this chart, the reader is advised that the authors, Hospital Pharmacy, or SAGE Publishing cannot be held responsible for the currency of the information, for any errors or omissions, or for any consequences that may arise. The reader should consult the product PI for the most updated information.
Table 1.
Injectable Drugs That Require Protection From Light During Storage, Preparation, or Administration.3,4,6 -649
Drug | Storage | Reconstitution | Dilution | Administration | Additional comments |
---|---|---|---|---|---|
Abatacept Orencia |
X | Protect from light by storing in the original package until time of use. 6 | |||
AbobotulinumtoxinA Dysport |
X | X | Protect from light. 7 Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. | ||
Adalimumab Humira |
X | Store in original carton until time of administration to protect from light. 8 | |||
Aducanumab-avwa Aduhelm |
X | Store in original carton until use to protect from light. 9 | |||
Aflibercept Eylea |
X | Store in the original carton until time of use to protect from light. 10 | |||
Ziv-Aflibercept Zaltrap |
X | Keep the vials in the original outer carton to protect from light. 11 | |||
Albumin, human
b
Albuminex Kedbumin |
X | Keep the vial stored in the outer carton in order to protect from light.12,13 | |||
Aldesleukin Proleukin |
X | Protect from light. 14 Store in carton until time of use. | |||
Alemtuzumab Lemtrada |
X | X | Store in original carton to protect from light. 15 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Alfentanil hydrochloride | X | Protect from light. 16 Retain in carton until time of use. | |||
Alglucosidase alfa Lumizyme |
X | X | X | Protect from light during storage. 4 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. 17 | |
Alirocumab Praluent |
X | Store in the original carton to protect from light. 18 | |||
Alteplase Activase Cathflo Activase |
X | Protect the lyophilized material during extended storage from excessive exposure to light.19,20 | |||
Amino acid preparations
b
Aminosyn II Aminosyn-PF Clinimix Clinimix E HepatAmine Plenamine Premasol ProcalAmine Prosol Travasol Trophamine |
X |
Aminosyn II, Aminosyn-PF: Avoid exposure to light.21,22
ProcalAmine, HepatAmine, Premasol, Plenamine: Protect from light until use.23 -26 Clinimix, Clinimix E, Prosol, Travasol: Protect the activated parenteral nutrition solution from light.27 -30 Trophamine: Protect from light. 31 Do not expose TrophAmine and/or TrophAmine containing admixed parenteral nutrition solution to light. |
|||
Aminophylline | X | Protect from light. 32 Store in carton until time of use. | |||
Amiodarone hydrochloride Nexterone |
X | Use carton to protect contents from light until used. 33 Light protection is not necessary during administration, but exposure to direct sunlight should be avoided. 3 | |||
Amisulpride Barhemsys |
X | Protect from light. 34 Amisulpride is subject to photodegradation. Administer within 12 h of removal of the vial from the protective carton. | |||
Amivantamab-vmjw Rybrevant |
X | Store in original carton to protect from light. 35 | |||
Amphotericin B | X | X | X | Protect against exposure to light prior to reconstitution. 36 Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. Solutions should be protected from light during administration. Several reports indicate that for short-term exposure, little difference in potency is observed between light-protected and light-exposed solutions. 3 | |
Amphotericin B lipid complex
b
Abelcet |
X | Store protected from exposure to light; retain in the carton until time of use. 37 | |||
Anakinra Kineret |
X | Protect from light. 38 Keep in original carton. | |||
Anifrolumab-fnia Saphnelo |
X | X | Store in original carton to protect from light. 39 Protect diluted solution from light. | ||
Ansuvimab-zykl Ebanga |
X | X | X | Store in original carton to protect from light. 40 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. | |
Antihemophilic factor, recombinant Advate Adynovate Afstyla Esperoct Jivi Kogenate FS Kovaltry Novoeight Nuwiq Obizur Recombinate Xyntha Xyntha Solofuse |
X | X |
Advate, Adynovate, Jivi, Kogenate FS, Kovaltry, Recombinate: Store in the original carton to protect from extreme exposure to light.41
-46
Afstyla: Store in the original box to protect from light. 47 Protect from direct sunlight. Esperoct, Novoeight, Nuwiq, Obizur: Store in the original package to protect from light.48 -51 Xyntha, Xyntha Solofuse: During storage, avoid prolonged exposure to light.52,53 Afstyla, Esperoct, Novoeight, Nuwiq: Protect mixed/reconstituted solutions from direct light/sunlight.47 -50 |
||
Antihemophilic factor, plasma-derived
b
Koate |
X | Store in original package to protect from light. 54 | |||
Antiinhibitor coagulant complex Feiba |
X | Store in the original package to protect from light. 55 | |||
Antithymocyte globulin, equine Atgam |
X | Store in the original carton to protect from light. 56 | |||
Antithymocyte globulin, rabbit Thymoglobulin |
X | Protect from light. 57 | |||
Argatroban | X | X | Retain in the original carton to protect from light.58,59 Prepared solutions should not be exposed to direct sunlight.
58
Concentrate for injection: Stability of diluted solutions of the concentrate for injection is affected by light exposure; refer to prescribing information or tertiary resources for details regarding storage of the concentrate for injection after dilution. 58 |
||
Aripiprazole
b
Abilify Maintena |
X | Protect the syringe from light by storing in the original package until time of use. 60 | |||
Artesunate | X | Keep protected from light. 61 | |||
Articaine hydrochloride and epinephrine bitartrate Septocaine |
X | Protect from light. 62 | |||
Ascorbic acid Ascor |
X | Protect from light. 63 Minimize exposure to light during preparation and administration; ascorbic acid is light sensitive. | |||
Asfotase alfa Strensiq |
X | Store in the original container protected from light until the time of use. 64 | |||
Asparaginase erwinia chrysanthemi-rywn, recombinant Rylaze |
X | Store in the original carton to protect from light. 65 | |||
Atezolizumab Tecentriq |
X | Store in original carton to protect from light. 66 | |||
Atoltivimab, maftivimab, and odesivimab-ebgn Inmazeb |
X | Prior to dilution, store in the original carton to protect from light. 67 | |||
Avelumab Bavencio |
X | X | Store in original package to protect from light. 68 Stability of diluted solutions may be affected by light exposure; refer to tertiary resources for details regarding storage after dilution. 4 | ||
Azathioprine sodium | X | Protect from light. 69 Retain in carton until time of use. | |||
Bacillus Calmette-Guerin (BCG) BCG vaccine TICE BCG |
X | X | Protect from direct sunlight during storage and after reconstitution.70,71 | ||
Belatacept Nulojix |
X | X | Protect from light by storing in the original package until time of use. 72 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. | ||
Belimumab Benlysta |
X | X |
All products: Keep the product in the original carton to protect from light until the time of use.
73
Vial for reconstitution: Protect the reconstituted solution from sunlight. 73 |
||
Bendamustine hydrochloride Belrapzo Bendeka Treanda |
X | Retain in original package until time of use to protect from light.74 -76 | |||
Benralizumab Fasenra |
X | Store in the original carton to protect from light. 77 | |||
Beractant Survanta |
X | Protect from light. 78 Store vials in carton until ready for use. | |||
Betamethasone acetate and betamethasone sodium phosphate Celestone Soluspan |
X | Protect from light. 79 | |||
Bevacizumab and biosimilars Alymsys (bevacizumab-maly) Avastin Mvasi (bevacizumab-awwb) Zirabev (bevacizumab-bvzr) |
X | Store in the original carton to protect from light.80 -83 | |||
Bezlotoxumab Zinplava |
X | Store in original carton to protect from light. 84 | |||
Blinatumomab Blincyto |
X | Store the drug and IV solution stabilizer vials in the original package and protect from light until time of use. 85 | |||
Bortezomib Velcade |
X | X | Retain in original package to protect from light. 86 Stability of reconstituted solutions is affected by light exposure; refer to prescribing information or tertiary resources for details regarding storage after reconstitution. | ||
Bremelanotide acetate Vyleesi |
X | Protect from light. 87 | |||
Brentuximab vedotin Adcetris |
X | Store in the original carton to protect from light. 88 | |||
Brexanolone Zulresso |
X | Store protected from light. 89 | |||
Brilliant Blue G TissueBlue Syringe |
X | Protect from light. 90 | |||
Brodalumab Siliq |
X | Store in the original carton to protect from light. 91 | |||
Brolucizumab-dbll Beovu |
X | Store in the outer carton to protect from light. 92 | |||
Bumetanide | X | Protect from light. 93 Retain in carton until ready to use. | |||
Bupivacaine and meloxicam Zynrelef |
X | Protect from light. 94 | |||
Bupivacaine hydrochloride
b
Marcaine |
X | Protect from light. 95 | |||
Bupivacaine hydrochloride and epinephrine bitartrate Marcaine with epinephrine Sensorcaine with epinephrine |
X | Protect from light.95,96 | |||
Buprenorphine hydrochloride
b
Buprenex |
X | Protect from prolonged exposure to light. 97 | |||
Burosumab-twza Crysvita |
X | Keep in the original carton to protect from light until time of use. 98 | |||
Butorphanol tartrate | X | Protect from light. 99 Retain in carton until time of use. | |||
C1 esterase inhibitor, human Berinert Cinryze Haegarda |
X | Store in the original carton to protect from light.100 -102 | |||
C1 esterase inhibitor, recombinant Ruconest |
X | Store in the original carton and protect from light. 103 | |||
Calaspargase pegol-mknl Asparlas |
X | X | Store in the original carton to protect from light. 104 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Calcitriol | X | Protect from light. 105 | |||
Canakinumab Ilaris |
X | Store in the original carton to protect from light. 106 | |||
Caplacizumab-yhdp Cablivi |
X | Store in the original carton to protect from light. 107 | |||
Carboplatin | X | Protect from light. 108 Premixed solutions require protection from light. 4 | |||
Carfilzomib Kyprolis |
X | Retain in original package to protect from light. 109 | |||
Carmustine BiCNU |
X | X | X | Must be protected from light in all forms. 4 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. 110 | |
Casimersen Amondys |
X | Store in original carton until ready for use to protect from light. 111 | |||
Cefazolin sodium | X | X | Protect from light. 112 Protect dual chamber formulations from light after removal of foil strip. 113 Protection from light is recommended for both the powder and its solutions. 3 | ||
Cefepime hydrochloride | X | Protect from light. 114 Protect dual chamber formulations from light after removal of foil strip. 115 | |||
Cefiderocol sulfate tosylate Fetroja |
X | X | Protect from light. 116 Store in the carton until time of use. Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Cefotaxime sodium | X | X | X | The dry material and solutions should be protected from excessive light. 117 | |
Cefotetan disodium Cefotan |
X | Protect from light. 118 Protect dual chamber formulations from light after removal of foil strip. 119 | |||
Cefoxitin sodium | X | Protect dual chamber formulations from light after removal of foil strip. 120 Other formulations do not require protection from light. | |||
Ceftazidime Fortaz Tazicef |
X | Protect from light.121,122 Protect dual chamber formulations from light after removal of foil strip. 123 | |||
Ceftazidime and avibactam sodium Avycaz |
X | Protect from light. 124 Store in carton until time of use. | |||
Ceftolozane sulfate and tazobactam sodium Zerbaxa |
X | Protect from light. 125 | |||
Ceftriaxone sodium | X | Protect from light. 126 Protect dual chamber formulations from light after removal of foil strip. 127 | |||
Cefuroxime sodium | X | Protect from light. 128 Protect dual chamber formulations from light after removal of foil strip. 129 | |||
Cemiplimab-rwlc Libtayo |
X | Protect from light. 130 | |||
Cerliponase alfa Brineura |
X | Store in original carton to protect from light. 131 | |||
Certolizumab pegol Cimzia |
X | Protect solution from light. 132 Store prefilled syringes in the original carton to protect from light. | |||
Cetrorelix Cetrotide |
X | Keep the packaged tray in the outer carton in order to protect it from light. 133 | |||
Chloroprocaine hydrochloride Clorotekal Nesacaine Nesacaine MPF |
X | Protect from light.134,135 Store in original outer container, protected from direct sunlight. 135 | |||
Chlorpromazine hydrochloride | X | Protect from light. 136 | |||
Choriogonadotropin alfa
b
Ovidrel |
X | Protect from light. 137 | |||
Ciprofloxacin Otiprio |
X |
All products: Protect from light.138,139
Otiprio: Store in the original container until dose preparation. 139 |
|||
Cisatracurium besylate Nimbex |
X | Protect from light. 140 | |||
Cisplatin | X | X | Protect unopened container from light. 141 Stability of diluted solutions is affected by light exposure; refer to prescribing information or tertiary resources for details regarding storage after dilution. | ||
Cladribine | X | When stored properly and protected from light, unopened vials are stable until the expiration date indicated on the package. 142 | |||
Clevidipine Cleviprex |
X | Protect from light.3,4 Storage in cartons protects against photodegradation. 143 | |||
Coagulation factor IX, recombinant
b
Alprolix Idelvion Ixinity Rebinyn |
X | X |
All products: Store in the original package to protect from light.144
-147
Alprolix: Protect reconstituted solution from direct sunlight. 144 Rebinyn: Keep mixed solution out of direct light. 147 |
||
Coagulation factor X, human Coagadex |
X | Store in original package to protect from light. 148 | |||
Conivaptan hydrochloride Vaprisol |
X | Protect from light until ready to use. 149 Do not remove container from overwrap until ready for use. The overwrap is a light barrier. | |||
Corticorelin ovine triflutate Acthrel |
X | Protect from light. 150 | |||
Crizanlizumab-tmca Adakveo |
X | X | Store and transport in the original carton to protect from light. 151 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Cyanocobalamin | X | The Vitamin B coenzymes are very unstable in light and require protection from light. 152 | |||
Cyclosporine Sandimmune |
X | Protect from light. 153 | |||
Cysteine hydrochloride Elcys |
X | Protect parenteral nutrition solution from light. 154 | |||
Cytarabine | X | Protect from light. 155 | |||
Dacarbazine | X | Protect from light. 156 | |||
Dactinomycin Cosmegen |
X | Protect from light. 157 | |||
Dantrolene sodium Dantrium Revonto Ryanodex |
X | X |
All products: Avoid prolonged exposure to light.158
-160
Dantrium, Revonto: Protect vial contents from direct light.158,159 Stability of reconstituted solutions is affected by direct light exposure; refer to prescribing information for details regarding storage after reconstitution. |
||
Daratumumab Darzalex |
X | X | Protect from light. 161 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Daratumumab and hyaluronidase-fihj Darzalex Faspro |
X | Store in the original carton to protect from light. 162 Keep out of direct sunlight. | |||
Darbepoetin alfa Aranesp |
X | Protect from light; store in the carton until use. 163 | |||
Dasiglucagon hydrochloride Zegalogue |
X | Store in the provided protective case and protect from light. 164 | |||
Daunorubicin and cytarabine liposome Vyxeos |
X | Store in original carton to protect from light. 165 | |||
Daunorubicin hydrochloride | X | Protect from light. 166 Protect from sunlight. 4 | |||
Denosumab Prolia Xgeva |
X |
Prolia: Keep in the original carton to protect from light. Protect from direct light.
167
Xgeva: Protect from direct light. 168 |
|||
Dexamethasone sodium phosphate | X | Protect from light. 169 Some manufacturers recommend storing in carton until time of use. | |||
Diatrizoate Cystografin Cystografin Dilute |
X | Protect from light.170,171 | |||
Diazepam | X | Protect from light. 172 | |||
Digoxin Lanoxin Lanoxin Pediatric |
X | Protect from light. 173 | |||
Dihydroergotamine mesylate D.H.E. 45 |
X | Use carton to protect contents from light until used. 174 | |||
Dimenhydrinate | X | Protect from light. 175 | |||
Dinutuximab Unituxin |
X | Protect from light until time of use by storing in the outer carton. 176 | |||
Diphenhydramine hydrochloride | X | Protect from light. 177 Some manufacturers recommend storing in a light-resistant container until time of use. 3 | |||
Dipyridamole | X | Keep covered in carton until time of use to protect from light.4,178 | |||
Docetaxel Taxotere |
X | Store in the original package to protect from light. 179 | |||
Dostarlimab-gxly Jemperli |
X | Store in the original carton to protect from light. 180 | |||
Doxercalciferol
b
Hectorol |
X | Store in the original carton to protect from light. 181 | |||
Doxorubicin hydrochloride | X | X | X | X | Retain in carton until time of use to protect from light. 182 Protect from light from preparation until completion of infusion. Doxorubicin is sensitive to light and should be protected from sunlight. 3 Liposomal doxorubicin does not require protection from light. |
Doxycycline hyclate Doxy 100 |
X | X | X | X | Retain in carton until time of use to protect from light. 183 Stability of reconstituted and diluted solutions is affected by direct sunlight and artificial light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. |
Droperidol | X | Protect from light. 184 Retain in carton until time of use. | |||
Dulaglutide Trulicity |
X | Protect from light. 185 Store in original carton until the time of administration. | |||
Dupilumab Dupixent |
X | Store in the original carton to protect from light. 186 Do not expose to direct sunlight. | |||
Durvalumab Imfinzi |
X | Store in original carton to protect from light. 187 | |||
Ecallantide Kalbitor |
X | Protect vials from light until use. 188 | |||
Eculizumab Soliris |
X | Store in the original carton to protect from light until time of use. 189 | |||
Edaravone Radicava |
X | Protect from light. 190 | |||
Efgartigimod alfa Vyvgart |
X | X | Store in the original carton to protect from light until time of use. 191 Protect diluted solution from light. | ||
Elapegademase-lvlr Revcovi |
X | Store in the original carton to protect from light. 192 | |||
Elosulfase alfa Vimizim |
X | Protect from light. 193 | |||
Elotuzumab Empliciti |
X | X | Protect from light by storing in the original package until time of use. 194 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Emapalumab-lzsg Gamifant |
X | Store in original carton to protect from light. 195 | |||
Emicizumab Hemlibra |
X | Store in the original carton to protect from light. 196 | |||
Ephedrine sulfate
b
Akovaz |
X | Store in original carton until time of use to protect from light.3,4,197 | |||
Epinephrine Adrenaclick Adrenalin Auvi-Q Epipen Epipen Jr. Symjepi |
X |
All products: Protect from light.198
-202 Epinephrine solution is light sensitive and deteriorates rapidly on exposure to light. Adrenaclick, Auvi-Q, Epipen, Epipen Jr., Symjepi: Store in the provided case/tube to protect from light.199 -202 |
|||
Epirubicin hydrochloride Ellence |
X | Protect from light. 203 Keep in original carton to protect from light. 4 | |||
Epoetin alfa and biosimilars Epogen Procrit Retacrit (epoetin alfa-epbx) |
X | Store vials in the original carton until use to protect from light.204 -206 | |||
Epoprostenol sodium Flolan Veletri |
X | X |
Flolan: Protect powder from light by keeping unopened vial in the carton.
207
Protect reconstituted solution from light if not used immediately.3,207
Veletri: The unopened vial should be kept in the carton and not exposed to direct sunlight. 208 Do not expose the reconstituted solution to direct sunlight. |
||
Eptifibatide | X | Protect from light until administration. 209 Some manufacturers recommend storing in the carton until administration. | |||
Eptinezumab-jjmr Vyepti |
X | Store in the original carton to protect from light until time of use. 210 | |||
Eravacycline dihydrochloride Xerava |
X | Protect from light. 211 Keep vial in carton until use. | |||
Erenumab-aooe Aimovig |
X | Store in the original carton to protect from light until time of use. 212 Prior to administration, allow to sit at room temperature for at least 30 min protected from direct sunlight. Once outside the carton, do not leave in direct sunlight. | |||
Esomeprazole sodium Nexium I.V. |
X | Protect from light. 213 Store in carton until time of use. | |||
Etanercept
a
Enbrel |
X | Store in the original carton to protect from light. 214 Keep out of direct sunlight. | |||
Etelcalcetide Parsabiv |
X | Store in the original carton to protect from light. 215 If removed from the original carton, do not expose to direct sunlight. | |||
Eteplirsen Exondys 51 |
X | Protect from light. 216 Store in the original carton until ready for use. | |||
Ethanolamine oleate Ethamolin |
X | Protect from light. 217 | |||
Ethiodized oil Lipiodol |
X | Protect from light. 218 Remove from carton only upon use. | |||
Etoposide phosphate
b
Etopophos |
X | Vial, powder: Keep vial in outer carton to protect from light. 219 Other formulations do not require protection from light. | |||
Evinacumab-dgnb Evkeeza |
X | Store the vial in the original carton to protect from light. 220 | |||
Evolocumab Repatha |
X | Store in the original carton to protect from light. 221 Do not leave in direct sunlight. | |||
Exenatide, synthetic Bydureon Bcise Byetta |
X |
All products: Protect from light.222,223
Bydureon Bcise: Store in the original package. 222 |
|||
Factor VIIa, recombinant NovoSeven RT SevenFACT |
X | X |
NovoSeven RT: Store protected from light.
224
SevenFact: Store in the product package to protect from light. 225 All products: Keep the reconstituted solution out of direct light.224,225 |
||
Factor XIII A-subunit, recombinant Tretten |
X | X | Store in the original package to protect from light. 226 Keep mixed solution out of direct sunlight. | ||
Factor XIII concentrate, human Corifact |
X | Keep in original carton to protect from light. 227 | |||
Faricimab Vabysmo |
X | Keep in the original carton to protect from light. 228 | |||
Fentanyl citrate | X | Protect from light.229,230 Some manufacturers recommend storing in carton or tray until time of use.3,229 | |||
Ferric pyrophosphate citrate Triferic Triferic Avnu |
X | Protect from light.231,232 Keep ampule in pouch until time of use. | |||
Fibrinogen concentrate, human Fibryga RiaSTAP |
X | Protect from light.233,234 Keep in the original carton until ready to use. | |||
Filgrastim and biosimilars Neupogen Nivestym (filgrastim-aafi) Releuko (filgrastim-avow) Zarxio (filgrastim-sndz) |
X |
All products: Store in the original carton to protect from light.235
-238
Neupogen, Nivestym: Do not leave in direct sunlight.235,236 |
|||
tbo-Filgrastim Granix |
X | Store in the original carton to protect it from light. 239 | |||
Fish oil triglycerides lipid emulsion Omegaven SMOFlipid |
X | Protect the admixed parenteral nutrition solution from light.240,241 | |||
Fluorouracil | X | Protect from light. 242 Some manufacturers recommend retaining in carton until time of use.3,242 Exposure to sunlight or intense incandescent light has caused degradation. 3 | |||
Fluphenazine decanoate | X | Keep in outer carton to protect from light. 243 | |||
Fluphenazine hydrochloride | X | Protect from light. 244 | |||
Folic acid | X | Protect from light. 245 Retain in carton until contents are used. | |||
Follitropin alfa Gonal-f Gonal-f RFF |
X | Protect from light.246,247 | |||
Follitropin beta Follistim AQ |
X | Protect from light. 248 | |||
Fosdenopterin hydrobromide Nulibry |
X | Store in the original carton to protect from light. 249 | |||
Fosnetupitant chloride hydrochloride and palonosetron hydrochloride Akynzeo |
X | Store in carton to protect from light. 250 | |||
Fremanezumab-vfrm Ajovy |
X | Store in the original outer carton to protect from light. 251 Do not expose to direct sunlight. | |||
Fulvestrant Faslodex |
X | Store in the original carton to protect from light until time of use. 252 | |||
Furosemide | X | X | Protect from light. 253 Photodegradation is minimized at pH 7 and occurs at a higher rate at more acidic or basic pH. 3 Exposure to light may cause discoloration. Stability of diluted solutions is affected by light exposure; refer to tertiary sources for details regarding storage after dilution. | ||
Gadodiamide Omniscan |
X | Protect from strong daylight and direct exposure to sunlight. 254 | |||
Gadoteridol ProHance |
X | Protect from light. 255 | |||
Galcanezumab-gnlm Emgality |
X | Store in the original carton to protect from light until use. 256 Protect from direct sunlight. | |||
Galsulfase Naglazyme |
X | Protect from light. 257 | |||
Ganirelix acetate Fyremadel |
X | Protect from light. 258 | |||
Gemtuzumab ozogamicin Mylotarg |
X | X | X | X | Store in the original carton to protect from light. 259 Protect the reconstituted and diluted solution from light in all concentrations.4,259 Protect the intravenous bag from light using a light-blocking cover during infusion. 259 The infusion line does not need to be protected from light. |
Glatiramer acetate Copaxone Glatopa |
X | Protect from light.260,261 Avoid exposure to intense light. | |||
Glucagon GlucaGen Gvoke |
X | Keep in original package to protect from light.262,263 | |||
Golimumab Simponi Simponi Aria |
X | Store in the original carton to protect from light until time of use.264,265 | |||
Golodirsen Vyondys |
X | Store in original carton until ready for use to protect from light. 266 | |||
Granisetron Sustol |
X |
All formulations: Protect from light.
267
Generic immediate-release injection: Retain in carton until time of use to protect from light. 268 |
|||
Guselkumab Tremfya |
X | Store in original carton until time of use to protect from light. 269 | |||
Haemophilus influenza type B conjugate vaccine
b
Hiberix |
X | Protect from light. 270 | |||
Haloperidol decanoate Haldol Decanoate |
X | Protect from light. 271 | |||
Haloperidol lactate | X | Keep in outer carton to protect from light. 272 | |||
Histamine skin test control Histatrol |
X | Protect from light. 273 | |||
Human papillomavirus vaccine Gardasil 9 |
X | Protect from light. 274 | |||
Hyaluronidase
b
Vitrase |
X | Protect from light. 275 | |||
Hydrocortisone sodium succinate Solu-Cortef |
X | Protect reconstituted solution from light. 276 | |||
Hydromorphone hydrochloride Dilaudid |
X | Protect from light. 277 All generic formulations (ampule, vial, carpuject, prefilled syringe) also require protection from light. | |||
Hydroxocobalamin | X | Protect from light. 278 | |||
Hydroxyprogesterone caproate Makena |
X | Keep in carton until time of use to protect from light. 279 | |||
Hydroxyzine hydrochloride | X | Protect from light. 280 | |||
Ibalizumab-uiyk Trogarzo |
X | Store in original carton to protect from light before use.4,281 | |||
Ibuprofen lysine NeoProfen |
X | Protect from light. 282 Store vials in carton until contents have been used. | |||
Idarubicin hydrochloride Idamycin PFS |
X | Protect from light. 283 Retain in carton until time of use. | |||
Idarucizumab Praxbind |
X | Store in the original carton to protect from light. 284 Unopened vials may be stored at room temperature for up to 48 h in the original carton or for up to 6 h if exposed to light. | |||
Idursulfase Elaprase |
X | Store in carton to protect from light. 285 | |||
Imipenem, cilastatin sodium, and relebactam Recarbrio |
X | Keep vials in the carton to protect from light.286,287 | |||
Immune globulin, human, and hyaluronidase Hyqvia |
X | Keep in the carton in order to protect from light. 288 | |||
Immune globulin, human
b
Cutaquig Cuvitru Flebogamma DIF Gammagard Liquid Gammaked Gammaplex Gamunex-C Hizentra Octagam Panzyga Privigen |
X |
Cutaquiz, Cuvitru, Flebogamma DIF, Gammaplex, Gammagard Liquid, Gammaked, Gamunex-C, Hizentra, Privigen: Keep in original carton to protect from light.289
-297
Octagam, Panzyga: Store protected from light.298,299 |
|||
Indigotindisulfonate Bludigo |
X | Store in original carton to protect from light. 300 | |||
Indomethacin sodium | X | Protect from light. 301 Store container in carton until contents have been used. | |||
Inebilizumab-cdon Uplizna |
X | Store in the original carton to protect from light. 302 | |||
Infliximab and biosimilars
b
Avsola (infliximab-axxq) Inflectra (infliximab-dyyb) Remicade |
X | X | X |
Avsola: Protect from light.
303
Avsola, Inflectra, Remicade: Stability of reconstituted or diluted solutions may be affected by light exposure; refer to tertiary resources for more details.3,303 -305 |
|
Influenza quadrivalent vaccine, inactivated, 2021-2022 season
b
Afluria Fluad Fluarix Flublok Flucelvax Flulaval |
X |
Afluria, Fluad, Flublok, Flucelvax: Protect from light.306
-310
Fluarix, Flulaval: Store in the original carton to protect from light.311,312 |
|||
Inotersen sodium Tegsedi |
X | Store in the original container and protect from direct light. 313 | |||
Inotuzumab ozogamicin Besponsa |
X | X | X | X | Store in the original carton to protect from light. 314 Protect reconstituted and diluted solutions of all concentrations from light.4,314 Refer to prescribing information for details regarding storage after reconstitution or dilution. |
Insulin aspart Fiasp Novolog |
X | Do not expose to light.315,316 Keep in the original packaging (including the pen cap) to protect from light. | |||
Insulin aspart and protamine Novolog Mix 70/30 |
X | Protect from light. 317 | |||
Insulin degludec Tresiba |
X |
Vial: Store in the original carton to protect from light, both before and during use.
318
Pen: While in use, keep away from light. 318 |
|||
Insulin degludec and liraglutide Xultophy |
X | Store in the carton to protect from light before use. 319 While in use, keep away from direct light. | |||
Insulin detemir Levemir |
X | Store in the carton to protect from light. 320 | |||
Insulin glargine Basaglar Lantus Lantus SoloStar Toujeo Toujeo Max |
X | Protect from light, both before and during use.321 -323 | |||
Insulin glargine and lixisenatide Soliqua |
X | Protect from light, both before and during use. 324 Replace the pen cap after each use to protect from light. | |||
Insulin glargine-aglr Rezvoglar |
X | Protect from light. 325 | |||
Insulin glargine-yfgn Semglee |
X | Protect from light, both before and during use. 326 | |||
Insulin glulisine Apidra Apidra SoloStar |
X | Protect from light, both before and during use. 327 | |||
Insulin isophane (NPH) and regular insulin Humulin 70/30 Novolin 70/30 |
X | Protect from light, both before and during use.328,329 | |||
Insulin lispro Admelog Humalog |
X | Protect from light, both before and during use.330,331 | |||
Insulin lispro and protamine Humalog Mix 50/50 Humalog Mix 75/25 |
X | Protect from light.332,333 Before and during use, keep vials away from direct light. 334 | |||
Insulin lispro-aabc Lyumjev |
X | Keep in the original carton to protect from light, both before and during use. 335 | |||
Insulin regular Humulin R Humulin R U-500 Myxredlin Novolin R |
X |
All products: Regular insulin should not be exposed to direct sunlight.336
-338
Humulin R, Humulin R U-500: Protect from light, both before and during use. 336 Myxredlin: Store in the original carton while refrigerated to protect from light. 337 Novolin R: Do not expose to light. 338 |
|||
Interferon beta-1a Avonex Rebif |
X |
Avonex prefilled syringes and autoinjectors: Store in the original carton to protect from light.
339
Rebif prefilled syringes and autoinjectors: Store away from light. 340 |
|||
Iodixanol Visipaque |
X | Protect from direct exposure to sunlight. 341 | |||
Iohexol Omnipaque |
X | Protect from light. 342 | |||
Iopamidol Isovue Isovue-M |
X | Protect from light.343,344 | |||
Iopramide Ultravist |
X | Protect from light. 345 | |||
Iothalamate meglumine Conray Cysto-Conray II |
X | Protect from strong daylight or direct exposure to the sun.346,347 | |||
Ioversol Optiray |
X | Protect from strong daylight or direct exposure to the sun. 348 | |||
Ipilimumab Yervoy |
X | Protect from light by storing in the original carton until time of use. 349 | |||
Irinotecan hydrochloride Camptosar |
X | X | Protect from light. 350 Keep vial in the carton until the time of use. Stability of diluted solutions may be affected by light exposure; refer to tertiary resources for more details. 3 | ||
Irinotecan hydrochloride, liposomal Onivyde |
X | X | Protect from light. 351 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Isatuximab-irfc Sarclisa |
X | Store in the original carton to protect from light. 352 | |||
Isoniazid | X | Protect from light. 353 Isoniazid is slowly affected by exposure to air and light. | |||
Isoproterenol hydrochloride Isuprel |
X | X | Protect from light. 354 Keep in opaque container until used. Stability of diluted solutions may be affected by light exposure; refer to tertiary resources for more details. 3 | ||
Ixabepilone Ixempra |
X | X | X | Store in the original package until time of use to protect from light. 355 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. | |
Ixekizumab Taltz |
X | Store in the original carton to protect from light. 356 | |||
Japanese encephalitis virus vaccine Ixiaro |
X | Store in the original package to protect from light. 357 | |||
Ketamine hydrochloride Ketalar |
X | Protect from light. 358 | |||
Ketorolac tromethamine | X | Protect from light. 359 Retain in carton until time of use. Prolonged exposure to light may result in discoloration of the solution and precipitation. 3 | |||
Labetalol hydrochloride | X | Protect from light.
360
Retain in carton until time of use. Premixed solution: Do not remove from overwrap until ready to use. 361 |
|||
Lanadelumab-flyo Takhzyro |
X | Keep in the original carton to protect from light. 362 | |||
Lanreotide acetate Somatuline Depot |
X | Protect from light. 363 Store in the original package. | |||
Laronidase Aldurazyme |
X | Protect from light. 364 | |||
Letermovir Prevymis |
X | Store in the original carton to protect from exposure to light. 365 | |||
Leucovorin calcium | X | Protect from light.366,367 Retain in carton until time of use. | |||
Leuprolide acetate
b
Camcevi |
X | Protect from light; store vial in carton until use. 368 Store prefilled syringe in the original package until use. 369 | |||
Levocarnitine b | X | Store in original carton to protect from light. 370 Carnitor does not require protection from light. | |||
Levofloxacin | X | X | Protect from light.371,372 Stability of diluted solutions may be affected by light exposure; refer to tertiary resources for more details. 3 | ||
Levoleucovorin calcium Fusilev Khapzory |
X | X | X |
All products: Protect from light.373,374 Store in carton until contents are used. Khapzory: Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. 374 |
|
Levothyroxine sodium | X | Protect from light in the original vial in a carton.375,376 The unopened vial may be stored for up to 24 h exposed to indoor lighting outside of the carton. | |||
Lidocaine hydrochloride
b
Xylocaine Xylocaine MPF |
X | Protect from light. 377 | |||
Lidocaine hydrochloride and epinephrine Xylocaine with Epi Xylocaine MPF with Epi |
X | Protect from light. 378 | |||
Linezolid Zyvox |
X | X | Premixed bags: Protect from light. 379 Keep infusion bags in the overwrap until ready to use. Duration of stability after removal from overwrap is affected by exposure to light. 380 | ||
Liraglutide Saxenda Victoza |
X |
All products: Protect from excessive sunlight.381,382
Saxenda: Put the pen cap on after each use to protect from light. 381 |
|||
Lixisenatide Adlyxin |
X | Keep in the original package to protect from light. 383 Replace the pen cap after each use to protect from light. | |||
Lonapegsomatropin-tcgd Skytrofa |
X | Store in the outer carton to protect from light. 384 | |||
Loncastuximab terisine-lypl Zynlonta |
X | X | Store in the original carton to protect from light. 385 Do not expose the reconstituted solution to direct sunlight. | ||
Lorazepam Ativan |
X | Use carton to protect contents from light. 386 | |||
Luspatercept-aamt Reblozyl |
X | Store in the original carton to protect from light. 387 | |||
Margetuximab-cmbk Margenza |
X | Store in the original carton to protect from light until time of use. 388 | |||
Measles, mumps, and rubella vaccine MMR II |
X | X | Exposure to light may inactivate vaccine viruses. 389 Protect reconstituted solution from light. | ||
Measles, mumps, rubella, and varicella vaccine Proquad |
X | X | Protect reconstituted solution from light. 390 Protect from light at all times since exposure to light may inactivate vaccine viruses. | ||
Meloxicam Anjeso |
X | Protect from light. 391 | |||
Melphalan hydrochloride Evomela |
X | Light sensitive. 392 Retain in original carton until use. | |||
Meningococcal conjugate vaccine
b
Menveo |
X | Protect from light. 393 | |||
Menotropins Menopur |
X | Protect from light. 394 | |||
Mepivacaine hydrochloride
b
Carbocaine 2% with Neo-Cobefrin 1:20,000 Carbocaine 3% Polocaine Dental 2% with Neo-Cobefrin 1:20,000 Polocaine Dental 3% |
X | Protect from light.395,396 Retain in box until time of use. Once opened, the box should be reclosed by closing the top flap. Non-dental formulations (eg, Carbocaine 1%-2% and Polocaine 1%-2%) do not require protection from light. | |||
Mepolizumab Nucala |
X | Store in the original carton to protect from light.
397
Prefilled autoinjector, prefilled syringe: Must be administered within 8 h of being taken out of the carton. 397 Keep away from direct sunlight. |
|||
Meropenem b | X | Protect dual-chamber formulations from light after removal of foil strip. 398 Merrem does not require protection from light. | |||
Mescasermin Increlex |
X | Protect from direct light. 399 | |||
Methadone hydrochloride | X | Protect from light. 400 Store in carton until contents have been used. | |||
Methotrexate Otrexup Rasuvo |
X | X | Protect from light.401 -404 Stability of diluted solutions may be affected by light exposure; refer to tertiary resources for more details. 3 | ||
Methoxy polyethylene glycol-epoetin beta Mircera |
X | Store in the original carton to protect from light. 405 Prolonged exposure to light should be avoided. | |||
Methylene blue ProvayBlue |
X | Store in the original package to protect from light. 406 | |||
Methylergonovine maleate Methergine |
X | Protect from light. 407 | |||
Methylnaltrexone bromide Relistor |
X | Vials and syringes: Protect from light. 408 | |||
Methylprednisolone sodium succinate Solu-Medrol |
X | Protect from light. 409 | |||
Metoclopramide hydrochloride | X | X | Protect from light. 410 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Metoprolol tartrate | X | Protect from light. 411 Retain in carton until time of use. | |||
Metreleptin Myalept |
X | X | Protect from light. 412 Keep vials in the carton when not in use. Reconstituted vial (with bacteriostatic water for injection) can be used for multiple doses within 3 d if protected from light. | ||
Metronidazole | X | Protect from light. 413 Direct sunlight should be avoided. 3 | |||
Micafungin sodium Mycamine |
X | X | X | Protect from light. 414 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. It is not necessary to cover the infusion drip chamber or the tubing. | |
Midazolam hydrochloride b | X | Vial: Some generic manufacturers require protection from light during storage. 415 Refer to the prescribing information for product-specific details on protection from light. | |||
Mitomycin Jelmyto Mitosol |
X | X | Protect from light.416 -418 Protect reconstituted solution from light. | ||
Mogamulizumab-kpkc Poteligeo |
X | Store in original package to protect from light until time of use. 419 | |||
Morphine sulfate Duramorph PF Infumorph Mitigo |
X | X | Protect from light.420 -422 Keep stored in carton until time of use. Stability of diluted solutions may be affected by light exposure; refer to tertiary resources for more details. 3 | ||
Moxetumomab padusotox-tdfk Lumoxiti |
X | X | X | Store the drug and IV solution stabilizer in the original carton to protect from light. 423 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. Protect from light during administration.4,423 | |
Nalbuphine hydrochloride | X | Protect from light. 424 Store in the carton until contents have been used. | |||
Naloxone hydrochloride Zimhi |
X | Store in the outer case provided to protect from light.425,426 | |||
Natalizumab Tysabri |
X | Protect from light. 427 | |||
Naxitamab-gqgk Danyelza |
X | Store in the outer carton to protect from light until time of use. 428 | |||
Necitumumab Portrazza |
X | Keep in the outer carton to protect from light. 429 | |||
Neostigmine methylsulfate Bloxiverz |
X | Protect from light. Store in carton until time of use. 430 | |||
Nicardipine hydrochloride Cardene I.V. |
X | Store in the carton to protect from light until ready to use.
431
Premixed bag: Protect from light until ready to use. 432 |
|||
Nitroglycerin | X | Protect from light.433,434 Retain in carton until time of use. The premixed solutions should be protected from light until time of use. 3 Although light protection is recommended by manufacturers, exposure to light, even high intensity light, does not adversely affect nitroglycerin stability. | |||
Nivolumab Opdivo |
X | X | Protect from light by storing in the original package until time of use. 435 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Nivolumab and relatlimab-rmbw Opdualag |
X | X | Store in the original carton to protect from light until time of use. 436 Stability of the diluted solution is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Norepinephrine bitartrate Levophed |
X | X | Store in the original carton until time of administration to protect from light.437,438 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. Premixed solution: Protect from light. 438 Keep in overwrap until ready to use. |
||
Nusinersen sodium Spinraza |
X | Store in the original carton to protect from light. 439 | |||
Obiltoxaximab Anthim |
X | Keep vials in their cartons prior to preparation of an infusion solution to protect from light. 440 | |||
Obinutuzumab Gazyva |
X | Protect from light. 441 | |||
Ocrelizumab Ocrevus |
X | Store in the outer carton to protect from light. 442 | |||
Octreotide acetate Sandostatin Sandostatin LAR |
X |
Sandostatin: Store in the outer carton to protect from light.
443
Sandostatin LAR: Protect from light until the time of use. 444 |
|||
Ofatumumab Arzerra Kesimpta |
X |
Arzerra: Protect from light.
445
Kesimpta: Keep the product in the original carton to protect from light until the time of use. 446 |
|||
Olanzapine Zyprexa IntraMuscular |
X | Protect from light. 447 | |||
Olanzapine pamoate Zyprexa Relprevv |
X | Keep away from sunlight. 448 | |||
Oliceridine Olinvyk |
X | Protect from light. 449 | |||
Omacetaxine mepesuccinate Synribo |
X | Prior to reconstitution, keep product in carton to protect from light. 450 | |||
Omalizumab Xolair |
X | X | Store in original carton to protect from direct sunlight. 451 Reconstituted vials should be protected from sunlight. | ||
Ondansetron hydrochloride | X | Retain in carton until time of use. 452 Protect from light. | |||
Orphenadrine citrate | X | Protect from light. 453 | |||
Oxaliplatin b | X | Protect the concentrated solution from light. 454 Keep in original outer carton. Lyophilized powder does not require protection from light. 455 | |||
Paclitaxel Abraxane |
X | X | X |
All products: Retain in the original package to protect from bright light.456,457
Abraxane: Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. 456 |
|
Pafolacianine Cytalux |
X | X | X | Store in original carton to protect from light. 458 Protect the infusion bag from light using a light-blocking cover during infusion and storage. | |
Palifermin Kepivance |
X | X | Store in the dispensing pack in the carton. 459 Protect from light. Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution.4,459 | ||
Palonosetron | X | Protect from light. 460 | |||
Panitumumab Vectibix |
X | Store in the original carton until time of use. 461 Protect from direct sunlight. | |||
Pantoprazole sodium Protonix I.V. |
X | Protect vials from light; use of vial carton is recommended. 462 | |||
Papaverine | X | Protect from light. 463 Retain in carton until time of use. | |||
Parathyroid hormone Natpara |
X | Prior to reconstitution, the dual-chamber medication cartridge should be stored in the package provided. 464 Store away from light. | |||
Pasireotide diaspartate Signifor |
X | Protect from light. 465 Pasireotide pamoate (Signifor LAR) does not require protection from light. | |||
Pegaspargase Oncaspar |
X | X | Store in the original carton to protect from light. 466 Protect infusion bag from direct sunlight. | ||
Pegcetacoplan Empaveli |
X | Keep the vial in the carton until ready for use to protect from light. 467 | |||
Pegfilgrastim and biosimilars Fulphila (pegfilgrastim-jmdb) Fylnetra (pegfilgrastim-pbbk) Neulasta, Neulasta Onpro Nyvepria (pegfilgrastim-apgf) Udenyca (pegfilgrastim-cbqv) Ziextenzo (pegfilgrastim-bmez) |
X | X | Keep the prefilled syringe in the original carton to protect from light.468 -473 Do not leave the prefilled syringes in direct sunlight. | ||
Peginterferon alfa-2a Pegasys |
X | Vial, prefilled syringe: Protect from light. 474 | |||
Peginterferon beta-1a Plegridy |
X | Store in the closed original carton to protect from light until ready for injection. 475 | |||
Pegloticase Krystexxa |
X | X | Protect from light. 476 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Pegvaliase-pqpz Palynziq |
X | Store in original carton to protect from light. 477 | |||
Pembrolizumab Keytruda |
X | Store in original carton to protect from light. 478 | |||
Pemetrexed disodium b | X | Solution for injection: Some generic manufacturers require protection from light during storage. 479 Refer to the prescribing information for product-specific details on protection from light. | |||
Pentamidine isethionate Pentam |
X | X | Protect from light. 480 Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. | ||
Peritoneal dialysis solutions Dianeal Low Calcium Dianeal PD-2 Extraneal |
X | Store in moisture barrier overwrap and in carton until ready to use.481,482 Storing in the carton prevents direct sun rays from falling into the transparent solution and container, which may potentially form glucose degradation products and reduce the effectiveness of the solution. 483 | |||
Pertuzumab Perjeta |
X | Keep vial in the outer carton in order to protect from light. 484 | |||
Pertuzumab, trastuzumab, and hyaluronidase-zzxf Phesgo |
X | Store in the original carton to protect from light. 485 | |||
Phentolamine mesylate
b
Oraverse |
X | Protect from direct heat and light. 486 | |||
Phenylephrine hydrochloride and ketorolac tromethamine Omidria |
X | Protect from light. 487 | |||
Phenylephrine hydrochloride
b
Vazculep |
X | Protect from light. 488 Store in carton until time of use. | |||
Phytonadione | X | X | X | Protect from light at all times. 489 Store container in closed original carton until contents have been used. | |
Polatuzumab vedotin-piiq Polivy |
X | Store in original carton to protect from light. 490 | |||
Polidocanol
b
Varithena |
X | Store the canisters away from sources of heat including strong light conditions. 491 | |||
Poliovirus vaccine, inactivated IPOL |
X | Protect from light. 492 | |||
Polymyxin B sulfate | X | Store in the original carton to protect from light. 493 | |||
Porfimer sodium Photofrin |
X | X | Store unopened vials in original carton to protect from light. 4 Reconstituted product should be protected from bright light. 494 | ||
Potassium phosphates, monobasic and dibasic | X | Protect the parenteral nutrition solution from light during storage. 495 | |||
PrabotulinumtoxinA-xvfs Jeuveau |
X | X | Store in the original carton to protect from light. 496 Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. | ||
Pralatrexate Folotyn |
X | Store in original carton to protect from light. 497 | |||
Pramlintide acetate Symlin |
X | Protect from light. 498 | |||
Prilocaine hydrochloride and epinephrine bitartrate Citanest Forte Dental |
X | Protect from light. 499 | |||
Prochlorperazine edisylate | X | Protect from light. 500 Store in the original carton until ready to use. | |||
Promethazine Phenergan |
X | Keep covered in carton until time of use to protect from light. 501 | |||
Propranolol hydrochloride | X | Protect from light. 502 | |||
Protein C concentrate, human Ceprotin |
X | Store in the original carton to protect it from light. 503 | |||
Pyridostigmine bromide Regonol |
X | Protect from light. 504 | |||
Pyridoxine hydrochloride | X | Protect from light. 505 | |||
Rabies vaccine
b
RabAvert |
X | Protect from light. 506 | |||
Ramucirumab Cyramza |
X | Store in the original carton to protect from light until time of use. 507 | |||
Ranibizumab and biosimilars Byooviz (ranibizumab-nuna) Lucentis Susvimo |
X | Protect prefilled syringes and vials from light and store in the original carton until time of use.508 -510 | |||
Rasburicase Elitek |
X | Protect from light. 511 | |||
Ravulizumab-cwvz Ultomiris |
X | X | Store in the original carton to protect from light. 512 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Raxibacumab | X | Keep vials in their cartons prior to preparation of an infusion solution to protect from light. 513 | |||
Remimazolam besylate Byfavo |
X | Protect vials from light once they are removed from packaging. 514 | |||
Reslizumab Cinqair |
X | X | Protect vials from light by storing in the original package until time of use. 515 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Reteplase Retavase |
X | Boxes should remain sealed until time of use to protect the lyophilisate from exposure to light. 516 | |||
Rho(D) immune globulin
b
Rhophylac WinRho SDF |
X |
Rhophylac: Keep in the original carton to protect from light.
517
WinRho SDF: Protect from light. 518 |
|||
Rifampin Rifadin |
X | Protect from light. 519 | |||
Rilonacept Arcalyst |
X | X | Store in the original carton to protect from light. 520 Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. | ||
RimabotulinumtoxinB Myobloc |
X | Store in the original carton to protect from light. 521 | |||
Risankizumab-rzaa Skyrizi |
X | X | Keep in the original cartons to protect from light.
522
Prefilled cartridge and prefilled pen: Prior to administration, allow to sit at room temperature for up to 90 min protected from direct sunlight. 522 Vial: stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. 522 |
||
Risperidone
b
Risperdal Consta |
X | The entire dose pack should be protected from light. 523 | |||
Rituximab and biosimilars Riabni (rituximab-arrx) Rituxan Ruxience (rituximab-pvvr) Truxima (rituximab-abbs) |
X | X |
All products: vials should be protected from direct sunlight.524
-527
Riabni: stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. 524 |
||
Rituximab and hyaluronidase Rituxan Hycela |
X | Store in the original carton to protect from light. 528 | |||
Romidepsin | X | Store in the carton to protect from light. 529 | |||
Romiplostim Nplate |
X | X | X | Store in the original carton to protect from light. 530 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. | |
Romosozumab-aqqg Evenity |
X | Store in the original carton to protect from light. 531 | |||
Ropeginterferon alfa-2b Besremi |
X | Store in the original carton to protect from light. 532 | |||
Sacituzumab govitecan-hziy Trodelvy |
X | X | X | Store in the original carton to protect from light until time of reconstitution. 533 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. Protect infusion bag from light. The infusion bag should be covered during administration to the patient until dosing is complete. It is not necessary to cover the infusion tubing or to use light-protective tubing during the infusion. | |
Sargramostim Leukine |
X | Store in the original carton to protect from light. 534 | |||
Sarilumab Kevzara |
X | Store in the original carton to protect from light. 535 | |||
Satralizumab-mwge Enspryng |
X | Store in the original carton to protect from light. 536 | |||
Sebelipase alfa Kanuma |
X | X | Store in the original carton to protect from light. 537 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Secretin, human ChiRhoStim |
X | Protect from light. 538 | |||
Secukinumab Cosentyx |
X | Store in the original carton to protect from light. 539 | |||
Selenious acid | X | Protect the admixed parenteral nutrition solution from light. 540 | |||
Selexipag Uptravi |
X | X | X | X | Protect from light at all times. 541 Store in the original carton until use in order to protect from light. Stability of reconstituted and diluted solutions is affected by light exposure. During reconstitution, ensure the protective wrap around label is covering the entire vial. After dilution, wrap the glass container completely with light protective cover. Refer to prescribing information for details regarding storage after reconstitution or dilution. |
Semaglutide Ozempic Wegovy |
X |
Ozempic: Keep the pen cap on when not in use. Protect from excessive sunlight.
542
Wegovy: Protect from light. Keep in original carton until time of administration. 543 |
|||
Setmelanotide acetate Imcivree |
X | Store unopened and opened vials in the original carton to protect from light. 544 | |||
Siltuximab Sylvant |
X | Store in the original carton to protect from light. 545 | |||
Sirolimus Fyarro |
X | Store in the original package to protect from light. 546 Stability of the reconstituted suspension and the diluted suspension is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution and dilution. | |||
Sodium hyaluronate and derivatives (ie, hyaluronic acid)
b
Biolon Euflexxa Gelsyn-3 GenVisc 850 Healon Endocoat Healon GV Pro Healon Pro Healon5 Pro Hyalgan Provisc Restylane Restylane Contour Restylane Defyne Restylane Kysse Restylane Lyft with Lidocaine Restylane Refyne Restylane Silk Restylane-L Revanesse Lips Revanesse Versa Triluron Trivisc |
X |
Biolon, Euflexxa, Healon products, Provisc: Protect from light.547
-553
Gelsyn-3: Protect from light by storing in the original packaging. 554 Use immediately after removal from the carton box. GenVisc 850, Hyalgan, Triluron, Trivisc: Protect from light by storing in the original packaging.555 -558 Revanesse Lips, Revanesse Versa: Protect from direct sunlight.559,560 Do not use with a laser or intense pulsed light. Restylane products: Protect from sunlight.561 -568 |
|||
Sodium nitrite | X | Protect from direct light. 569 | |||
Sodium nitrite and sodium thiosulfate Nithiodote |
X | Protect from direct light. 570 | |||
Sodium nitroprusside Nipride RTU |
X | X | X | Store in the carton until used to protect from light. 571 Stability of diluted solutions may be affected by light exposure; refer to tertiary resources for more details. Diluted solutions should be wrapped in an opaque sleeve; amber plastic bags do not provide sufficient protection against photodegradation.3,4 Sources are conflicting regarding protection of tubing during administration. | |
Sodium thiosulfate | X | Protect from direct light. 572 | |||
Somapacitan-beco Sogroya |
X | Store pre-filled pen with the cap on in the original carton to protect from light. 573 | |||
Somatropin
b
Genotropin/Genotropin Miniquick Humatrope Norditropin Nutropin AQ Nuspin Omnitrope Saizen Zomacton |
X | X |
All products: Protect from light.574
-580
Humatrope: Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. 575 |
||
Sotalol hydrochloride | X | Protect from light. 581 | |||
Streptomycin sulfate | X | X | Protect from light. 582 Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. | ||
Streptozocin Zanosar |
X | Store in the original carton to protect from light. 583 | |||
Sufentanil citrate | X | Protect from light. 584 | |||
Sugammadex sodium Bridion |
X | Protect from light. 585 When not protected from light, the vial should be used within 5 d. | |||
Sumatriptan succinate Imitrex STATdose Zembrace SymTouch |
X | Protect from light.586,587 | |||
Sutimlimab-jome Enjaymo |
X | Store in the original carton to protect from light. 588 | |||
Tafasitamab-cxix Monjuvi |
X | X | X | Store in the original carton to protect from light. 589 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. | |
Tagraxofusp-erzs Elzonris |
X | Store in the original carton to protect from light. 590 | |||
Taliglucerase alfa Elelyso |
X | X | X | Store in the original carton to protect from light. 591 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. | |
Talimogene laherparepvec Imlygic |
X | Store in the original carton to protect from light during storage and during and after thawing the product. 592 | |||
Tebentafusp Kimmtrak |
X | Store in the original carton to protect from light until time of use. 593 | |||
Technetium TC-99M Bicisate Kit Neurolite |
X | Protect vial A from light. 594 | |||
Technetium TC-99M mertiatide
b
Technescan MAG3 |
X | Protect from light. 595 | |||
Technetium TC-99M tetrofosmin Myoview |
X | Protect the kit from light. 596 | |||
Temsirolimus Torisel |
X | X | X | Protect from light. 597 Stability of reconstituted or diluted solutions is affected by excessive room light and sunlight; refer to prescribing information for details regarding storage after reconstitution or dilution. | |
Teniposide | X | Store in original package to protect from light. 598 | |||
Teprotumumab-trbw Tepezza |
X | X | X | Store in the original carton to protect from light. 599 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. | |
Terbutaline sulfate | X | Store in the original carton to protect from light. 600 | |||
Teriparatide Forteo |
X | Recap the delivery device (pen) when not in use to protect from light. 601 | |||
Tesamorelin acetate Egrifta SV |
X | Store in the original box to protect from light. 602 | |||
Testosterone cypionate Depo-Testosterone |
X | Protect from light. 603 | |||
Testosterone enanthate
b
Xyosted |
X | Store in the original carton to protect from light. 604 | |||
Tetracaine hydrochloride | X | Protect from light. 605 | |||
Tezepelumab-ekko Tezspire |
X | Store in original carton to protect from light until time of use. 606 | |||
Thiamine hydrochloride | X | Protect from light. 607 | |||
Thiotepa b | X | Protect from light at all times. 608 Tepadina and certain generic manufacturers of thiotepa do not require protection from light. Other generic manufactures state to protect from light at all times. Refer to the prescribing information for product-specific details on protection from light. | |||
Thyrotropin alfa Thyrogen |
X | Store in the original carton to protect from light. 609 | |||
Tildrakizumab-asmn Ilumya |
X | Store in the original carton to protect from light. 610 | |||
Tirofiban hydrochloride Aggrastat |
X | Protect from light during storage. 611 | |||
Tirzepatide Mounjaro |
X | Store in the original carton to protect from light. 612 | |||
Tisotumab vedotin-tftv Tivdak |
X | Store in the original carton to protect from light. 613 | |||
Tocilizumab Actemra |
X | X | Protect the vials, syringes, and autoinjectors from light by storage in the original package until time of use. 614 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Topotecan hydrochloride Hycamtin |
X | X |
All products: Store in the original carton to protect from light.615,616
Powder for reconstitution: Reconstituted product diluted for infusion should be protected from light; refer to prescribing information for details regarding storage after dilution. 615 |
||
Tralokinumab-ldrm Adbry |
X | Store in the original carton to protect from light. 617 Do not expose to direct sunlight. | |||
Trastuzumab and hyaluronidase-oysk Herceptin Hylecta |
X | Store in the original carton to protect from light. 618 If the solution is drawn into a syringe and is not used immediately, then the syringe can be stored and should be protected from light; refer to prescribing information for details regarding storage. | |||
Trastuzumab biosimilars
b
Kanjinti (trastuzumab-anns) Trazimera (trastuzumab-qyyp) |
X | Store in the original carton to protect from light.619,620 | |||
fam-Trastuzumab deruxtecan-nxki Enhertu |
X | X | X | X | Store in the original carton to protect from light until reconstitution. 621 If not used immediately, store the reconstituted vials protected from light. Cover the infusion bag to protect from light. Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. |
Triamcinolone acetonide, intravitreal Triesence |
X | Store in the original carton to protect from light. 622 | |||
Triamcinolone acetonide, suprachoroidal Xipere |
X | Store in the carton to protect from light. 623 | |||
Triamcinolone acetonide
b
Kenalog-10 Kenalog-40 Kenalog-80 |
X | Store in the original carton to protect from light.624 -626 | |||
Trypan blue VisionBlue |
X | Protect from direct sunlight. 627 | |||
Tuberculin skin test Aplisol Tubersol |
X | Protect from light.628,629 | |||
Ustekinumab Stelara |
X | Keep the product in the original carton to protect from light until the time of use. 630 | |||
Varicella virus vaccine, live Varivax |
X | Protect from light. 631 | |||
Varicella zoster vaccine, live attenuated Shingrix Zostavax |
X | Protect from light.632,633 | |||
Vecuronium bromide | X | Store in the original carton to protect from light. 634 | |||
Vedolizumab Entyvio |
X | Store in the original carton to protect from light. 635 | |||
Velaglucerase alfa Vpriv |
X | X | X | Store in the original carton to protect from light. 636 Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. | |
Verapamil hydrochloride | X | X | Store in the original carton to protect from light. 637 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Verteporfin Visudyne |
X | X | Stability of reconstituted and diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution or dilution. 638 | ||
Vestronidase alfa-vjbk Mepsevii |
X | Protect from light. 639 | |||
Vinblastine sulfate | X | Store in the original carton to protect from light. 640 | |||
Vincristine sulfate | X | X | Protect from light. 641 Stability of diluted solutions is affected by light exposure; refer to prescribing information for details regarding storage after dilution. | ||
Vinorelbine tartrate | X | Store in the original carton to protect from light. 642 | |||
Vitamin A palmitate Aquasol A |
X | Protect from light. 643 | |||
Von Willebrand factor/coagulation factor VIII complex Wilate |
X | Store in the original carton to protect from light. 644 | |||
Vosoritide Voxzogo |
X | Store in the original package to protect from light. 645 | |||
Ziconotide acetate, intrathecal Prialt |
X | Protect from light. 646 | |||
Zidovudine Retrovir |
X | Protect from light. 647 | |||
Zinc sulfate | X | Protect the admixed parenteral nutrition solution from light. 648 | |||
Ziprasidone mesylate Geodon |
X | X | Protect from light. 649 Stability of reconstituted solutions is affected by light exposure; refer to prescribing information for details regarding storage after reconstitution. |
Biosimilars for this product were approved but not yet marketed at the time of article publication.
Other formulations do not require protection from light.
Footnotes
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.
ORCID iDs: Jessica M. Elste
https://orcid.org/0000-0002-7561-2656
Heather J. Ipema
https://orcid.org/0000-0002-0981-1358
Christie Denton
https://orcid.org/0000-0002-8850-5390
Faria Munir
https://orcid.org/0000-0001-6642-498X
References
- 1. University of Illinois at Chicago College of Pharmacy, Drug Information Group. Light-sensitive injectable prescription drugs. Hosp Pharm. 2014;49(2):136-163. doi: 10.1310/hpj4902-136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. U.S. Food and Drug Administration. FDALabel: full-text search of drug product labeling. 2022. Accessed October 2021. https://www.fda.gov/science-research/bioinformatics-tools/fdalabel-full-text-search-drug-product-labeling .
- 3. American Society of Health-System Pharmacists. ASHP injectable drug information. Updated January 11, 2022. Accessed August 2022. https://www-medicinescomplete-com.proxy.cc.uic.edu/#/browse/hid
- 4. Collins SR. Gahart’s 2022 Intravenous Medications: A Handbook for Nurses and Health Professionals. 38th ed. Elsevier; 2022. Accessed August 2022. https://www-clinicalkey-com.proxy.cc.uic.edu/#!/content/book/3-s2.0-B9780323825092000021 [Google Scholar]
- 5. U.S. Food and Drug Administration. Drugs@FDA: FDA-approved drugs. 2022. Accessed August 2022. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm.
- 6. Orencia. Package insert. Bristol-Myers Squibb Company; 2021. [Google Scholar]
- 7. Dysport. Package insert. Ipsen Biopharmaceuticals, Inc.; 2020. [Google Scholar]
- 8. Humira. Package insert. AbbVie Inc.; 2021. [Google Scholar]
- 9. Aduhelm. Package insert. Biogen Inc.; 2022. [Google Scholar]
- 10. Eylea. Package insert. Regeneron Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 11. Zaltrap. Package insert. Sanofi-Aventis U.S. LLC; 2020. [Google Scholar]
- 12. Albuminex. Package insert. Bio Products Laboratory USA Inc.; 2018. [Google Scholar]
- 13. Kedbumin. Package insert. Kedrion Biopharma, Inc.; 2020. [Google Scholar]
- 14. Proleukin. Package insert. Clinigen, Inc.; 2019. [Google Scholar]
- 15. Lemtrada. Package insert. Genzyme Corporation; 2022. [Google Scholar]
- 16. Alfentanil hydrochloride.Package insert. Hospira, Inc.; 2020. [Google Scholar]
- 17. Lumizyme. Package insert. Genzyme Corporation; 2022. [Google Scholar]
- 18. Praluent. Package insert. Regeneron Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 19. Activase. Package insert.Genentech, Inc.; 2018. [Google Scholar]
- 20. Cathflo Activase.Package insert. Genentech, Inc.; 2019. [Google Scholar]
- 21. Aminosyn II. Package insert. ICU Medical, Inc.; 2019. [Google Scholar]
- 22. Aminosyn-PF. Package insert. ICU Medical, Inc.; 2018. [Google Scholar]
- 23. ProcalAmine. Package insert. B. Braun Medical Inc.; 2019. [Google Scholar]
- 24. HepatAmine. Package insert. B. Braun Medical Inc.; 2019. [Google Scholar]
- 25. Premasol. Package insert. Baxter; 2014. [Google Scholar]
- 26. Plenamine. Package insert. B. Braun Medical Inc.; 2020. [Google Scholar]
- 27. Clinimix. Package insert. Baxter; 2021. [Google Scholar]
- 28. Clinimix E. Package insert. Baxter; 2021. [Google Scholar]
- 29. Prosol. Package insert. Baxter; 2020. [Google Scholar]
- 30. Travasol. Package insert. Baxter; 2020. [Google Scholar]
- 31. Trophamine. Package insert. B. Braun Medical Inc.; 2020. [Google Scholar]
- 32. Aminophylline injection. Package insert. Hospira, Inc.; 2018. [Google Scholar]
- 33. Nexterone. Package insert. Baxter Healthcare Corporation; 2021. [Google Scholar]
- 34. Barhemsys. Package insert. Acacia Pharma Inc.; 2022. [Google Scholar]
- 35. Rybrevant. Package insert. Janssen Biotech, Inc.; 2021. [Google Scholar]
- 36. Amphotericin B. Package insert. XGen Pharmaceuticals DJB, Inc.; 2020. [Google Scholar]
- 37. Abelcet. Package insert. Leadiant Biosciences, Inc.; 2018. [Google Scholar]
- 38. Kineret. Package insert. Swedish Orphan Biovitrum AB (publ); 2020. [Google Scholar]
- 39. Saphnelo. Package insert. AstraZeneca Pharmaceuticals LP; 2021. [Google Scholar]
- 40. Ebanga. Package insert. Ridgeback Biotherapeutics, LP; 2022. [Google Scholar]
- 41. Advate. Package insert. Baxalta US Inc.; 2018. [Google Scholar]
- 42. Adynovate. Package insert. Baxalta US Inc.; 2021. [Google Scholar]
- 43. Jivi. Package insert. Bayer HealthCare LLC; 2018. [Google Scholar]
- 44. Kogenate FS. Package insert. Bayer HealthCare LLC; 2019. [Google Scholar]
- 45. Kovaltry. Package insert. Bayer HealthCare LLC; 2021. [Google Scholar]
- 46. Recombinate. Package insert. Baxalta US Inc.; 2018. [Google Scholar]
- 47. Afstyla. Package insert. CSL Behring LLC; 2021. [Google Scholar]
- 48. Esperoct. Package insert. Novo Nordisk Inc.; 2019. [Google Scholar]
- 49. Novoeight. Package insert. Novo Nordisk Inc.; 2020. [Google Scholar]
- 50. Nuwiq. Package insert. Octapharma USA, Inc.; 2021. [Google Scholar]
- 51. Obizur. Package insert. Baxalta US Inc.; 2021. [Google Scholar]
- 52. Xyntha. Package insert. Pfizer; 2020. [Google Scholar]
- 53. Xyntha Solofuse. Package insert. Pfizer; 2020. [Google Scholar]
- 54. Koate. Package insert. Kedrion Biopharma Inc.; 2018. [Google Scholar]
- 55. Feiba. Package insert. Baxalta US Inc.; 2020. [Google Scholar]
- 56. Atgam. Package insert. Pharmacia & Upjohn Co; 2021. [Google Scholar]
- 57. Thymoglobulin. Package insert. Genzyme Corporation; 2020. [Google Scholar]
- 58. Argatroban injection. Package insert. Hikma Pharmaceuticals USA Inc.; 2020. [Google Scholar]
- 59. Argatroban solution. Package insert. Gland Pharma Limited; 2017. [Google Scholar]
- 60. Abilify Maintena. Package insert. Otsuka Pharmaceutical Co., Ltd.; 2020. [Google Scholar]
- 61. Artesunate injection. Package insert. Amivas, Inc.; 2021. [Google Scholar]
- 62. Septocaine. Package insert. Septodont Inc.; 2019. [Google Scholar]
- 63. Ascor. Package insert. McGuff Pharmaceuticals, Inc.; 2022. [Google Scholar]
- 64. Strensiq. Package insert. Alexion Pharmaceuticals, Inc.; 2020. [Google Scholar]
- 65. Rylaze. Package insert. Jazz Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 66. Tecentriq. Package insert. Genentech, Inc.; 2022. [Google Scholar]
- 67. Inmazeb. Package insert. Regeneron Pharmaceuticals, Inc.; 2022. [Google Scholar]
- 68. Bavencio. Package insert. EMD Serono, Inc.; 2020. [Google Scholar]
- 69. Azathioprine sodium injection. Package insert. West-Ward Pharmaceuticals Corp.; 2019. [Google Scholar]
- 70. BCG vaccine. Package insert. Merck & Co., Inc.; 2021. [Google Scholar]
- 71. TICE BCG. Package insert. Merck & Co., Inc.; 2021. [Google Scholar]
- 72. Nulojix. Package insert. Bristol-Myers Squibb Company; 2021. [Google Scholar]
- 73. Benlysta. Package insert. GlaxoSmithKline; 2021. [Google Scholar]
- 74. Belrapzo. Package insert. Eagle Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 75. Bendeka. Package insert. Teva Pharmaceuticals USA, Inc.; 2021. [Google Scholar]
- 76. Treanda. Package insert. Cephalon, Inc.; 2021. [Google Scholar]
- 77. Fasenra. Package insert. AstraZeneca Pharmaceuticals LP; 2021. [Google Scholar]
- 78. Survanta. Package insert. AbbVie Inc.; 2020. [Google Scholar]
- 79. Celestone Soluspan. Package insert. Merck & Co., Inc.; 2018. [Google Scholar]
- 80. Alymsys. Package insert. Amneal Pharmaceuticals LLC; 2022. [Google Scholar]
- 81. Avastin. Package insert. Genentech, Inc.; 2021. [Google Scholar]
- 82. Mvasi. Package insert. Amgen Inc.; 2021. [Google Scholar]
- 83. Zirabev. Package insert. Pfizer Inc.; 2021. [Google Scholar]
- 84. Zinplava. Package insert. Merck & Co., Inc.; 2016. [Google Scholar]
- 85. Blincyto. Package insert. Amgen Inc.; 2022. [Google Scholar]
- 86. Velcade. Package insert. Takeda Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 87. Vyleesi. Package insert. Palatin Technologies, Inc.; 2021. [Google Scholar]
- 88. Adcetris. Package insert. Seagen Inc.; 2019. [Google Scholar]
- 89. Zulresso. Package insert. Sage Therapeutics, Inc.; 2022. [Google Scholar]
- 90. TissueBlue Syringe. Package insert. Dutch Ophthalmic, USA; 2019. [Google Scholar]
- 91. Siliq. Package insert. Bausch Health US, LLC; 2020. [Google Scholar]
- 92. Beovu. Package insert. Novartis Pharmaceuticals Corporation; 2022. [Google Scholar]
- 93. Bumetanide injection. Package insert. Hospira, Inc.; 2021. [Google Scholar]
- 94. Zynrelef. Package insert. Heron Therapeutics, Inc.; 2021. [Google Scholar]
- 95. Marcaine and Marcaine with epinephrine. Package insert. Hospira, Inc.; 2020. [Google Scholar]
- 96. Sensorcaine and Sensorcaine MPF. Package insert. Fresenius Kabi USA, LLC; 2019. [Google Scholar]
- 97. Buprenex. Package insert. Indivior Inc.; 2022. [Google Scholar]
- 98. Crysvita. Package insert. Ultragenyx Pharmaceutical Inc.; 2020. [Google Scholar]
- 99. Butorphanol tartrate injection. Package insert. Hikma Pharmaceuticals USA Inc.; 2020. [Google Scholar]
- 100. Berinert. Package insert. CSL Behring LLC; 2021. [Google Scholar]
- 101. Cinryze. Package insert. ViroPharma Biologics LLC; 2021. [Google Scholar]
- 102. Haegarda. Package insert. CSL Behring LLC; 2020. [Google Scholar]
- 103. Ruconest. Package insert. Pharming Healthcare Inc.; 2020. [Google Scholar]
- 104. Asparlas. Package insert. Servier Pharmaceuticals LLC; 2021. [Google Scholar]
- 105. Calcitriol injection. Package insert. Gland Pharma Limited; 2017. [Google Scholar]
- 106. Ilaris. Package insert. Novartis Pharmaceuticals Corporation; 2020. [Google Scholar]
- 107. Cablivi. Package insert. Genzyme Corporation; 2022. [Google Scholar]
- 108. Carboplatin injection. Package insert. Fresenius Kabi USA, LLC; 2021. [Google Scholar]
- 109. Kyprolis. Package insert. Amgen Inc.; 2022. [Google Scholar]
- 110. BiCNU. Package insert. Avet Pharmaceuticals Inc.; 2021. [Google Scholar]
- 111. Amondys. Package insert. Sarepta Therapeutics, Inc.; 2021. [Google Scholar]
- 112. Cefazolin sodium powder for solution. Package insert. Samson Medical Technologies, L.L.C.; 2020. [Google Scholar]
- 113. Cefazolin and dextrose injection solution. Package insert. B. Braun Medical Inc.; 2021. [Google Scholar]
- 114. Cefepime hydrochloride powder for solution. Package insert. Sagent Pharmaceuticals; 2021. [Google Scholar]
- 115. Cefepime and dextrose injection solution. Package insert. B. Braun Medical Inc.; 2018. [Google Scholar]
- 116. Fetroja. Package insert. Shionogi Inc.; 2021. [Google Scholar]
- 117. Cefotaxime injection. Package insert. Hikma Pharmaceuticals USA Inc.; 2021. [Google Scholar]
- 118. Cefotan. Package insert. Teligent Pharma, Inc.; 2018. [Google Scholar]
- 119. Cefotetan and dextrose injection solution. Package insert. B. Braun Medical Inc.; 2020. [Google Scholar]
- 120. Cefoxitin and dextrose injection solution. Package insert. B. Braun Medical Inc.; 2019. [Google Scholar]
- 121. Fortaz. Package insert. Teligent Pharma, Inc.; 2019. [Google Scholar]
- 122. Tazicef. Package insert. Hospira, Inc.; 2020. [Google Scholar]
- 123. Ceftazidime and dextrose injection solution. Package insert. B. Braun Medical Inc.; 2021. [Google Scholar]
- 124. Avycaz. Package insert. Allergan, Inc.; 2020. [Google Scholar]
- 125. Zerbaxa. Package insert. Merck & Co., Inc.; 2022. [Google Scholar]
- 126. Ceftriaxone powder for injection. Package insert. Hikma Pharmaceuticals USA Inc.; 2019. [Google Scholar]
- 127. Ceftriaxone and dextrose injection solution. Package insert. B. Braun Medical Inc.; 2022. [Google Scholar]
- 128. Cefuroxime powder for injection. Package insert. Hikma Pharmaceuticals USA Inc.; 2021. [Google Scholar]
- 129. Cefuroxime and dextrose injection solution. Package insert. B. Braun Medical Inc.; 2020. [Google Scholar]
- 130. Libtayo. Package insert. Regeneron Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 131. Brineura. Package insert. BioMarin Pharmaceutical Inc.; 2020. [Google Scholar]
- 132. Cimzia. Package insert. UCB, Inc.; 2019. [Google Scholar]
- 133. Cetrotide. Package insert. EMD Serono, Inc.; 2018. [Google Scholar]
- 134. Clorotekal. Package insert. B. Braun Medical, Inc.; 2018. [Google Scholar]
- 135. Nesacaine and Nesacaine MPF. Package insert. Fresenius Kabi; 2019. [Google Scholar]
- 136. Chlorpromazine. Package insert. Hikma Pharmaceuticals USA Inc.; 2020. [Google Scholar]
- 137. Ovidrel. Package insert. EMD Serono, Inc.; 2018. [Google Scholar]
- 138. Ciprofloxacin injection solution. Package insert. Baxter; 2020. [Google Scholar]
- 139. Otiprio. Package insert. ALK-Abelló, Inc.; 2021. [Google Scholar]
- 140. Nimbex. Package insert. AbbVie Inc.; 2019. [Google Scholar]
- 141. Cisplatin. Package insert. Fresenius Kabi USA, LLC; 2017. [Google Scholar]
- 142. Cladribine. Package insert. Hikma Pharmaceuticals USA Inc.; 2019. [Google Scholar]
- 143. Cleviprex. Package insert. Chiesi USA, Inc.; 2021. [Google Scholar]
- 144. Alprolix. Package insert. Bioverativ Therapeutics Inc.; 2020. [Google Scholar]
- 145. Idelvion. Package insert. CSL Behring; 2021. [Google Scholar]
- 146. Ixinity. Package insert. Medexus Pharma, Inc.; 2021. [Google Scholar]
- 147. Rebinyn. Package insert. Novo Nordisk; 2020. [Google Scholar]
- 148. Coagadex. Package insert. Bio Products Laboratory Limited; 2020. [Google Scholar]
- 149. Vaprisol. Package insert. Cumberland Pharmaceuticals Inc.; 2017. [Google Scholar]
- 150. Acthrel. Package insert. Ferring Pharmaceuticals Inc.; 2018. [Google Scholar]
- 151. Adakveo. Package insert. Novartis Pharmaceuticals Corporation; 2021. [Google Scholar]
- 152. Cyanocobalamin. Package insert. Fresenius Kabi USA, LLC; 2018. [Google Scholar]
- 153. Sandimmune. Package insert. Novartis Pharmaceuticals Corporation; 2021. [Google Scholar]
- 154. Elcys. Package insert. Exela Pharma Sciences, LLC; 2019. [Google Scholar]
- 155. Cytarabine injection. Package insert. Mylan Institutional LLC; 2020. [Google Scholar]
- 156. Dacarbazine injection. Package insert. Teva Pharmaceuticals USA, Inc.; 2020. [Google Scholar]
- 157. Cosmegen. Package insert. Recordati Rare Diseases, Inc.; 2018. [Google Scholar]
- 158. Dantrium. Package insert. Par Pharmaceuticals; 2016. [Google Scholar]
- 159. Revonto. Package insert. USWM, LLC; 2020. [Google Scholar]
- 160. Ryandodex. Package insert. Eagle Pharmaceuticals, Inc.; 2020. [Google Scholar]
- 161. Darzalex. Package insert. Janssen Biotech, Inc.; 2022. [Google Scholar]
- 162. Darzalex Faspro. Package insert. Janssen Biotech, Inc.; 2022. [Google Scholar]
- 163. Aranesp. Package insert. Amgen Inc.; 2019. [Google Scholar]
- 164. Zegalogue. Package insert. Zealand Pharma US, Inc.; 2021. [Google Scholar]
- 165. Vyxeos. Package insert. Jazz Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 166. Daunorubicin. Package insert. Hisun Pharmaceuticals USA Inc.; 2019. [Google Scholar]
- 167. Prolia. Package insert. Amgen Inc.; 2022. [Google Scholar]
- 168. Xgeva. Package insert. Amgen Inc.; 2020. [Google Scholar]
- 169. Dexamethasone sodium phosphate. Package insert. Somerset Therapeutics, LLC; 2021. [Google Scholar]
- 170. Cystografin. Package insert. Bracco Diagnostics Inc.; 2018. [Google Scholar]
- 171. Cystografin Dilute. Package insert. Bracco Diagnostics Inc.; 2018. [Google Scholar]
- 172. Diazepam injection. Package insert. Hikma Pharmaceuticals USA Inc.; 2021. [Google Scholar]
- 173. Lanoxin and Lanoxin Pediatric. Package insert. Covis Pharma US, Inc.; 2020. [Google Scholar]
- 174. D.H.E. 45. Package insert. Bausch Health US, LLC; 2022. [Google Scholar]
- 175. Dimenhydrinate. Package insert. Fresenius Kabi USA, LLC; 2008. [Google Scholar]
- 176. Unituxin. Package insert. United Therapeutics Corporation; 2020. [Google Scholar]
- 177. Diphenhydramine. Package insert. Mylan Institutional LLC; 2021. [Google Scholar]
- 178. Dipyridamole. Package insert. West-ward Pharmaceuticals; 2011. [Google Scholar]
- 179. Taxotere. Package insert. Sanofi-Aventis U.S. LLC; 2022. [Google Scholar]
- 180. Jemperli. Package insert. GlaxoSmithKline; 2022. [Google Scholar]
- 181. Hectorol. Package insert. Genzyme Corporation; 2018. [Google Scholar]
- 182. Doxorubicin. Package insert. Hikma Pharmaceuticals USA Inc.; 2021. [Google Scholar]
- 183. Doxy 100. Package insert. Fresenius Kabi USA, LLC; 2020. [Google Scholar]
- 184. Droperidol. Package insert. American Regent, Inc.; 2009. [Google Scholar]
- 185. Trulicity. Package insert. Eli Lilly and Company; 2022. [Google Scholar]
- 186. Dupixent. Package insert. Sanofi-Aventis U.S. LLC; 2022. [Google Scholar]
- 187. Imfinzi. Package insert. AstraZeneca Pharmaceuticals LP; 2022. [Google Scholar]
- 188. Kalbitor. Package insert. Takeda Pharmaceuticals U.S.A., Inc.; 2021. [Google Scholar]
- 189. Soliris. Package insert. Alexion Pharmaceuticals, Inc.; 2020. [Google Scholar]
- 190. Radicava. Package insert. Mitsubishi Tanabe Pharma America, Inc.; 2021. [Google Scholar]
- 191. Vyvgart. Package insert. Argenx US, Inc.; 2022. [Google Scholar]
- 192. Revcovi. Package insert. Chiesi USA, Inc.; 2021. [Google Scholar]
- 193. Vimizim. Package insert. BioMarin Pharmaceutical Inc.; 2019. [Google Scholar]
- 194. Empliciti. Package insert. Bristol-Myers Squibb Company; 2022. [Google Scholar]
- 195. Gamifant. Package insert. Swedish Orphan Biovitrum AB; 2020. [Google Scholar]
- 196. Hemlibra. Package insert. Genentech, Inc.; 2021. [Google Scholar]
- 197. Akovaz. Package insert. Exela Pharma Sciences, LLC; 2021. [Google Scholar]
- 198. Adrenalin. Package insert. Par Pharmaceutical; 2020. [Google Scholar]
- 199. Adrenaclick. Package insert. Amneal Pharmaceuticals LLC; 2021. [Google Scholar]
- 200. Auvi-Q. Package insert. Kaleo, Inc.; 2019. [Google Scholar]
- 201. Epipen and Epipen Jr. Package insert. Mylan Specialty L.P.; 2020. [Google Scholar]
- 202. Symjepi. Package insert. Adamis Pharmaceuticals Corp.; 2021. [Google Scholar]
- 203. Ellence. Package insert. Pharmacia & Upjohn Co.; 2020. [Google Scholar]
- 204. Epogen. Package insert. Amgen Inc.; 2018. [Google Scholar]
- 205. Procrit. Package insert. Amgen Inc.; 2018. [Google Scholar]
- 206. Retacrit. Package insert. Pfizer Laboratories; 2020. [Google Scholar]
- 207. Flolan. Package insert. GlaxoSmithKline; 2021. [Google Scholar]
- 208. Veletri. Package insert. Actelion Pharmaceuticals US, Inc.; 2021. [Google Scholar]
- 209. Eptifibatide. Package insert. AuroMedics Pharma LLC; 2021. [Google Scholar]
- 210. Vyepti. Package insert. Lundbeck Seattle BioPharmaceuticals, Inc.; 2021. [Google Scholar]
- 211. Xerava. Package insert. Tetraphase Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 212. Aimovig. Package insert. Amgen, Inc.; 2021. [Google Scholar]
- 213. Nexium. Package insert. AstraZeneca Pharmaceuticals LP; 2022. [Google Scholar]
- 214. Enbrel. Package insert. Immunex Corporation; 2022. [Google Scholar]
- 215. Parsabiv. Package insert. Amgen Inc.; 2021. [Google Scholar]
- 216. Exondys 51. Package insert. Sarepta Therapeutics; 2022. [Google Scholar]
- 217. Ethamolin. Package insert. QOL Medical; 2019. [Google Scholar]
- 218. Lipiodol. Package insert. Guerbet LLC; 2020. [Google Scholar]
- 219. Etopophos. Package insert. H2-Pharma, LLC; 2019. [Google Scholar]
- 220. Evkeeza. Package insert. Regeneron Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 221. Repatha. Package insert. Amgen Inc.; 2021. [Google Scholar]
- 222. Bydureon Bcise. Package insert. AstraZeneca Pharmaceuticals LP; 2022. [Google Scholar]
- 223. Byetta. Package insert. AstraZeneca Pharmaceuticals LP; 2022. [Google Scholar]
- 224. NovoSeven RT. Package insert. Novo Nordisk Inc.; 2020. [Google Scholar]
- 225. SevenFACT. Package insert. HEMA Biologics; 2020. [Google Scholar]
- 226. Tretten. Package insert. Novo Nordisk Inc.; 2020. [Google Scholar]
- 227. Corifact. Package insert. CSL Behring LLC; 2020. [Google Scholar]
- 228. Vabysmo. Package insert. Genentech, Inc.; 2022. [Google Scholar]
- 229. Fentanyl. Package insert. Hospira, Inc.; 2019. [Google Scholar]
- 230. Fentanyl. Package insert. Akorn; 2021. [Google Scholar]
- 231. Triferic. Package insert. Rockwell Medical, Inc.; 2020. [Google Scholar]
- 232. Triferic Avnu. Package insert. Rockwell Medical, Inc.; 2020. [Google Scholar]
- 233. Fibryga. Package insert. Octapharma USA Inc.; 2020. [Google Scholar]
- 234. RiaSTAP. Package insert. CSL Behring LLC; 2021. [Google Scholar]
- 235. Neupogen. Package insert. Amgen Inc.; 2021. [Google Scholar]
- 236. Nivestym. Package insert. Pfizer Labs; 2021. [Google Scholar]
- 237. Releuko. Package insert. Amneal Biosciences, LLC; 2022. [Google Scholar]
- 238. Zarxio. Package insert. Sandoz Inc.; 2021. [Google Scholar]
- 239. Granix. Package insert. Cephalon, Inc.; 2020. [Google Scholar]
- 240. Omegaven. Package insert. Fresenius Kabi; 2020. [Google Scholar]
- 241. SMOFlipid. Package insert. Fresenius Kabi; 2022. [Google Scholar]
- 242. Fluorouracil. Package insert. Xiromed, LLC; 2021. [Google Scholar]
- 243. Fluphenazine decanoate. Package insert. AuroMedics Pharma LLC; 2021. [Google Scholar]
- 244. Fluphenazine hydrochloride. Package insert. Fresenius Kabi; 2016. [Google Scholar]
- 245. Folic acid. Package insert. XGen Pharmaceuticals DJB, Inc.; 2020. [Google Scholar]
- 246. Gonal-f. Package insert. EMD Serono, Inc.; 2020. [Google Scholar]
- 247. Gonal-f RFF. Package insert. EMD Serono, Inc.; 2020. [Google Scholar]
- 248. Follistim AQ. Package insert. Merck & Co, Inc.; 2020. [Google Scholar]
- 249. Nulibry. Package insert. Origin Biosciences, Inc.; 2021. [Google Scholar]
- 250. Akynzeo. Package insert. Helsinn Therapeutics (U.S.), Inc.; 2021. [Google Scholar]
- 251. Ajovy. Package insert. Teva Pharmaceuticals USA, Inc.; 2021. [Google Scholar]
- 252. Faslodex. Package insert. AstraZeneca Pharmaceuticals LP; 2021. [Google Scholar]
- 253. Furosemide. Package insert. Wockhardt USA LLC; 2021. [Google Scholar]
- 254. Omniscan. Package insert. GE Healthcare Inc.; 2019. [Google Scholar]
- 255. ProHance. Package insert. Bracco Diagnostics Inc.; 2021. [Google Scholar]
- 256. Emgality. Package insert. Eli Lilly and Company; 2021. [Google Scholar]
- 257. Naglazyme. Package insert. BioMarin Pharmaceutical Inc.; 2019. [Google Scholar]
- 258. Fyremadel. Package insert. Ferring Pharmaceuticals Inc.; 2022. [Google Scholar]
- 259. Mylotarg. Package insert. Wyeth Pharmaceuticals LLC; 2021. [Google Scholar]
- 260. Copaxone. Package insert. Teva Neuroscience, Inc.; 2022. [Google Scholar]
- 261. Glatopa. Package insert. Sandoz Inc.; 2020. [Google Scholar]
- 262. GlucaGen. Package insert. Boehringer Ingleheim Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 263. Gvoke. Package insert. Xeris Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 264. Simponi. Package insert. Janssen Biotech, Inc.; 2019. [Google Scholar]
- 265. Simponi Aria. Package insert. Janssen Biotech, Inc.; 2021. [Google Scholar]
- 266. Vyondys. Package insert. Sarepta Therapeutics, Inc.; 2021. [Google Scholar]
- 267. Sustol. Package insert. Heron Therapeutics; 2017. [Google Scholar]
- 268. Granisetron immediate release injection. Package insert. Akorn, Inc.; 2022. [Google Scholar]
- 269. Tremfya. Package insert. Janssen Biotech, Inc.; 2020. [Google Scholar]
- 270. Hiberix. Package insert. GlaxoSmithKline Biologicals; 2019. [Google Scholar]
- 271. Haldol Decanoate. Package insert. Janssen Pharmaceuticals, Inc.; 2020. [Google Scholar]
- 272. Haloperidol lactate. Package insert. Fresenius Kabi; 2021. [Google Scholar]
- 273. Histatrol. Package insert. Alk-Abello, Inc.; 2008. [Google Scholar]
- 274. Gardasil 9. Package insert. Merck Sharp & Dohme Corp.; 2021. [Google Scholar]
- 275. Vitrase. Package insert. Bausch + Lomb; 2018. [Google Scholar]
- 276. Solu-Cortef. Package insert. Pharmacia & Upjohn Co.; 2021. [Google Scholar]
- 277. Dilaudid. Package insert. Fresenius Kabi; 2020. [Google Scholar]
- 278. Hydroxocobalamin. Package insert. Actavis Pharma, Inc.; 2017. [Google Scholar]
- 279. Makena. Package insert. AMAG Pharmaceuticals, Inc.; 2018. [Google Scholar]
- 280. Hydroxyzine. Package insert. American Regent, Inc.; 2016. [Google Scholar]
- 281. Trogarzo. Package insert. Theratechnologies Inc.; 2021. [Google Scholar]
- 282. NeoProfen. Package insert. Recordati Rare Diseases Inc.; 2021. [Google Scholar]
- 283. Idamycin PFS. Package insert. Pharmacia & Upjohn Co.; 2022. [Google Scholar]
- 284. Praxbind. Package insert. Boehringer Ingelheim Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 285. Elaprase. Package insert. Takeda Pharmaceuticals U.S.A., Inc.; 2021. [Google Scholar]
- 286. Recarbrio. Package insert. Merck Sharp & Dohme Corp.; 2021. [Google Scholar]
- 287. Recarbrio. Customized response letter. Merck Sharp & Dohme Corp.; 2022. [Google Scholar]
- 288. Hyqvia. Package insert. Baxalta US Inc.; 2021. [Google Scholar]
- 289. Cutaquig. Package insert. Octapharma USA Inc.; 2021. [Google Scholar]
- 290. Cuvitru. Package insert. Baxalta US Inc.; 2021. [Google Scholar]
- 291. Flebogamma DIF. Package insert. Grifols Therapeutics LLC; 2019. [Google Scholar]
- 292. Gammagard Liquid. Package insert. Baxalta US Inc.; 2021. [Google Scholar]
- 293. Gammaked. Package insert. Grifols Therapeutics LLC; 2020. [Google Scholar]
- 294. Gammaplex. Package insert. Bio Products Laboratory Ltd.; 2019. [Google Scholar]
- 295. Gamunex-C. Package insert. Grifols Therapeutics LLC; 2020. [Google Scholar]
- 296. Hizentra. Package insert. CSL Behring LLC; 2021. [Google Scholar]
- 297. Privigen. Package insert. CSL Behring LLC; 2022. [Google Scholar]
- 298. Octagam. Package insert. Octapharma USA Inc.; 2021. [Google Scholar]
- 299. Panzyga. Package insert. Octapharma USA Inc.; 2021. [Google Scholar]
- 300. Bludigo. Package insert. Provepharm Inc.; 2022. [Google Scholar]
- 301. Indomethacin sodium. Package insert. Hospira; 2021. [Google Scholar]
- 302. Uplinza. Package insert. Horizon Therapeutics, Inc.; 2021. [Google Scholar]
- 303. Avsola. Package insert. Amgen; 2021. [Google Scholar]
- 304. Inflectra. Package insert. Pfizer; 2021. [Google Scholar]
- 305. Remicade. Package insert. Janssen; 2021. [Google Scholar]
- 306. Afluria quadrivalent. Package insert. Seqirus; 2021. [Google Scholar]
- 307. Fluad quadrivalent. Package insert. Seqirus; 2021. [Google Scholar]
- 308. Flublok quadrivalent. Package insert. Sanofi Pasteur; 2021. [Google Scholar]
- 309. Flucelvax quadrivalent multi-dose vial. Package insert. Seqirus; 2021. [Google Scholar]
- 310. Flucelvax quadrivalent prefilled syringe. Package insert. Seqirus; 2021. [Google Scholar]
- 311. Fluarix quadrivalent. Package insert. GlaxoSmithKline Biologicals SA; 2021. [Google Scholar]
- 312. Flulaval quadrivalent. Package insert. ID Biomedical Corp; 2021. [Google Scholar]
- 313. Tegsedi. Package insert. Akcea Therapeutics, Inc.; 2021. [Google Scholar]
- 314. Besponsa. Package insert. Wyeth Pharmaceuticals LLC; 2018. [Google Scholar]
- 315. Fiasp. Package insert. Novo Nordisk Inc.; 2019. [Google Scholar]
- 316. Novolog. Package insert. Novo Nordisk Inc.; 2021. [Google Scholar]
- 317. Novolog Mix 70/30. Package insert. Novo Nordisk Inc.; 2021. [Google Scholar]
- 318. Tresiba. Package insert. Novo Nordisk Inc.; 2022. [Google Scholar]
- 319. Xultophy. Package insert. Novo Nordisk; 2022. [Google Scholar]
- 320. Levemir. Package insert. Novo Nordisk Inc.; 2022. [Google Scholar]
- 321. Basaglar. Package insert. Eli Lilly and Company; 2021. [Google Scholar]
- 322. Lantus. Package insert. Sanofi-Aventis U.S. LLC; 2022. [Google Scholar]
- 323. Toujeo. Package insert. Sanofi-Aventis U.S. LLC; 2020. [Google Scholar]
- 324. Soliqua. Package insert. Sanofi-Aventis U.S. LLC; 2022. [Google Scholar]
- 325. Rezvoglar. Package insert. Eli Lilly and Company; 2021. [Google Scholar]
- 326. Semglee. Package insert. Mylan Pharmaceuticals Inc.; 2021. [Google Scholar]
- 327. Apidra and Apidra SoloStar. Package insert. Sanofi-Aventis U.S. LLC; 2020. [Google Scholar]
- 328. Humulin 70/30. Package insert. Lilly USA, LLC; 2022. [Google Scholar]
- 329. Novolin 70/30. Package insert. Novo Nordisk Inc.; 2019. [Google Scholar]
- 330. Admelog. Package insert. Sanofi-Aventis U.S. LLC; 2020. [Google Scholar]
- 331. Humalog. Package insert. Lilly USA, LLC; 2019. [Google Scholar]
- 332. Humalog Mix 50/50. Package insert. Lilly USA, LLC; 2019. [Google Scholar]
- 333. Humalog Mix 75/25. Package insert. Lilly USA, LLC; 2019. [Google Scholar]
- 334. Humalog Mix 75/25. Communication with manufacturer. Lilly USA, LLC; 2022. [Google Scholar]
- 335. Lyumjev. Package insert. Eli Lilly and Company; 2021. [Google Scholar]
- 336. Humulin R Humulin R U-500. Package insert. Lilly USA, LLC; 2022. [Google Scholar]
- 337. Myxredlin. Package insert. Baxter Healthcare Corporation; 2020. [Google Scholar]
- 338. Novolin R. Package insert. Novo Nordisk Inc.; 2019. [Google Scholar]
- 339. Avonex. Package insert. Biogen, Inc.; 2021. [Google Scholar]
- 340. Rebif. Package insert. EMD Serono, Inc.; 2021. [Google Scholar]
- 341. Visipaque. Package insert. GE Healthcare, Inc.; 2022. [Google Scholar]
- 342. Omnipaque. Package insert. GE Healthcare, Inc.; 2022. [Google Scholar]
- 343. Isovue. Package insert. Bracco Diagnostics; 2022. [Google Scholar]
- 344. Isovue-M. Package insert. Bracco Diagnostics; 2021. [Google Scholar]
- 345. Ultravist. Package insert. Bayer Healthcare; 2022. [Google Scholar]
- 346. Conray. Package insert. Guerbet; 2022. [Google Scholar]
- 347. Cysto-Conray II. Package insert. Guerbet; 2017. [Google Scholar]
- 348. Optiray. Package insert. Liebel-Flarsheim; 2022. [Google Scholar]
- 349. Yervoy. Package insert. E.R. Squibb & Sons; 2022. [Google Scholar]
- 350. Camposar. Package insert. Pfizer; 2022. [Google Scholar]
- 351. Onivyde. Package insert. Ipsen; 2020. [Google Scholar]
- 352. Sarclisa. Package insert. Sanofi-Aventis; 2021. [Google Scholar]
- 353. Isoniazid. Package insert. Sandoz; 2019. [Google Scholar]
- 354. Isuprel. Package insert. Bausch Health; 2020. [Google Scholar]
- 355. Ixempra. Package insert. R-Pharm US Operating, LLC; 2022. [Google Scholar]
- 356. Taltz. Package insert. Eli Lilly; 2021. [Google Scholar]
- 357. Ixiaro. Package insert. Valneva Scotland Ltd; 2018. [Google Scholar]
- 358. Ketalar. Package insert. Par Pharmaceuticals; 2020. [Google Scholar]
- 359. Ketorolac tromethamine. Package insert. Fresenius Kabi; 2020. [Google Scholar]
- 360. Labetalol hydrochloride. Package insert. Hospira; 2021. [Google Scholar]
- 361. Labetalol hydrochloride in sodium chloride. Package insert. Hikma; 2020. [Google Scholar]
- 362. Takhzyro. Package insert. Takeda Pharmaceuticals; 2022. [Google Scholar]
- 363. Somatuline Depot. Package insert. Ipsen Biopharmaceuticals Inc.; 2019. [Google Scholar]
- 364. Aldurazyme. Package insert. Genzyme; 2019. [Google Scholar]
- 365. Prevymis. Package insert. Merck Sharp & Dohme Corp; 2021. [Google Scholar]
- 366. Leucovorin calcium solution. Package insert. Fresenius Kabi; 2018. [Google Scholar]
- 367. Leucovorin calcium, powder, lyophilized for solution. Package insert. Hikma; 2021. [Google Scholar]
- 368. Leuprolide acetate. Package insert. Sandoz; 2021. [Google Scholar]
- 369. Camcevi. Package insert. Accord BioPharma Inc.; 2021. [Google Scholar]
- 370. Levocarnitine. Package insert. American Regent; 2019. [Google Scholar]
- 371. Levofloxacin. Package insert. Akorn; 2020. [Google Scholar]
- 372. Levofloxacin in 5% Dextrose. Package insert. Auromedics; 2021. [Google Scholar]
- 373. Fusilev. Package insert. Acrotech Biopharma; 2020. [Google Scholar]
- 374. Khapzory. Package insert. Acrotech Biopharma; 2020. [Google Scholar]
- 375. Levothyroxine. Package insert. Fresenius Kabi; 2020. [Google Scholar]
- 376. Levothyroxine lyophilized powder. Package insert. Maia Pharma; 2019. [Google Scholar]
- 377. Xylocaine. Package insert. Fresenius Kabi; 2020. [Google Scholar]
- 378. Xylocaine with epinephrine. Package insert. Fresenius Kabi; 2020. [Google Scholar]
- 379. Zyvox. Package insert. Pharmacia & Upjohn Company LLC; 2021. [Google Scholar]
- 380. Linezolid. Personal communication. Hospira; 2022. [Google Scholar]
- 381. Saxenda. Package insert. Novo Nordisk; 2022. [Google Scholar]
- 382. Victoza. Package insert. Novo Nordisk; 2022. [Google Scholar]
- 383. Adlyxin. Package insert. Sanofi-Aventis; 2022. [Google Scholar]
- 384. Skytrofa. Package insert. Ascendis Pharma Endocrinology, Inc.; 2022. [Google Scholar]
- 385. Zynlonta. Package insert. ADC Therapeutics; 2021. [Google Scholar]
- 386. Ativan. Package insert. Hikma; 2021. [Google Scholar]
- 387. Reblozyl. Package insert. Celgene Corp; 2022. [Google Scholar]
- 388. Margenza. Package insert. Macrogenics; 2020. [Google Scholar]
- 389. MMR II. Package insert. Merck Sharp & Dohme; 2020. [Google Scholar]
- 390. Proquad. Package insert. Merck Sharp & Dohme; 2021. [Google Scholar]
- 391. Anjeso. Package insert. Baudax Bio; 2021. [Google Scholar]
- 392. Evomela. Package insert. Acrotech Biopharma; 2022. [Google Scholar]
- 393. Menveo. Package insert. GlaxoSmithKline; 2020. [Google Scholar]
- 394. Menopur. Package insert. Ferring Pharmaceuticals; 2018. [Google Scholar]
- 395. Carbocaine and Carbocaine with Neo-Cobefrin. Package insert. Septodont; 2020. [Google Scholar]
- 396. Polocaine Dental and Polocaine Dental with Neo-Cobefrin. Package insert. Dentsply Pharmaceutical; 2020. [Google Scholar]
- 397. Nucala. Package insert. GlaxoSmithKline; 2022. [Google Scholar]
- 398. Meropenem and sodium chloride injection. Package insert. B. Braun Medical; 2020. [Google Scholar]
- 399. Increlex. Package insert. Ipsen Biopharmaceuticals; 2019. [Google Scholar]
- 400. Methadone hydrochloride. Package insert. Mylan; 2021. [Google Scholar]
- 401. Methotrexate injection. Package insert. Accord Pharma; 2021. [Google Scholar]
- 402. Methotrexate lyophilized powder for injection. Package insert. Fresenius Kabi; 2021. [Google Scholar]
- 403. Rasuvo. Package insert. Medexus Pharma; 2020. [Google Scholar]
- 404. Otrexup. Package insert. Antares Pharma; 2019. [Google Scholar]
- 405. Mircera. Package insert. Vifor Inc.; 2018. [Google Scholar]
- 406. Provayblue. Package insert. American Regent; 2021. [Google Scholar]
- 407. Methergine. Package insert. Novartis; 2012. [Google Scholar]
- 408. Relistor. Package insert. Salix Pharmaceuticals; 2020. [Google Scholar]
- 409. Solu-Medrol. Package insert. Pharmacia & UpJohn Company; 2021. [Google Scholar]
- 410. Metoclopramide. Package insert. Fresenius Kabi; 2021. [Google Scholar]
- 411. Metoprolol injection solution. Package insert. Hospira; 2020. [Google Scholar]
- 412. Myalept. Package insert. Amryt Pharmaceuticals; 2022. [Google Scholar]
- 413. Metronidazole. Package insert. Hospira; 2021. [Google Scholar]
- 414. Mycamine. Package insert. Astellas; 2020. [Google Scholar]
- 415. Midazolam hydrochloride. Package insert. Exela Pharma Sciences; 2022. [Google Scholar]
- 416. Mitomycin. Package insert. Gland Pharma; 2021. [Google Scholar]
- 417. Jelmyto. Package insert. UroGen Pharma, Inc.; 2021. [Google Scholar]
- 418. Mitosol. Package insert. Mobius Therapeutics, LLC; 2021. [Google Scholar]
- 419. Poteligeo. Package insert. Kyowa Kirin; 2022. [Google Scholar]
- 420. Duramorph PF. Package insert. Hikma; 2020. [Google Scholar]
- 421. Infumorph. Package insert. Hikma; 2020. [Google Scholar]
- 422. Mitigo. Package insert. Piramal Critical Care; 2021. [Google Scholar]
- 423. Lumoxiti. Package insert. AstraZeneca; 2022. [Google Scholar]
- 424. Nalbuphine. Package insert. Hospira; 2020. [Google Scholar]
- 425. Naloxone. Package insert. Hikma; 2022. [Google Scholar]
- 426. Zimhi. Package insert. USWM; 2021. [Google Scholar]
- 427. Tysabri. Package insert. Biogen; 2021. [Google Scholar]
- 428. Danyelza. Package insert. Y-mabs Therapeutics; 2020. [Google Scholar]
- 429. Portrazza. Package insert. Eli Lilly; 2015. [Google Scholar]
- 430. Bloxiverz. Package insert. Exela Pharma; 2021. [Google Scholar]
- 431. Nicardipine. Package insert. Hikma; 2020. [Google Scholar]
- 432. Cardene I.V. Package insert. Baxter; 2020. [Google Scholar]
- 433. Nitroglycerin in dextrose. Package insert. Baxter; 2016. [Google Scholar]
- 434. Nitroglycerin. Package insert. American Regent; 2005. [Google Scholar]
- 435. Opdivo. Package insert. E.R. Squibb & Sons; 2021. [Google Scholar]
- 436. Opdualag. Package insert. Bristol-Myers Squibb Company; 2022. [Google Scholar]
- 437. Levophed. Package insert. Hospira; 2020. [Google Scholar]
- 438. Norepinephrine bitartrate injection, solution. Package insert. Baxter Healthcare Corporation; 2021. [Google Scholar]
- 439. Spinraza. Package insert. Biogen; 2020. [Google Scholar]
- 440. Anthim. Package insert. Elusys Therapeutics; 2019. [Google Scholar]
- 441. Gazyva. Package insert. Genentech; 2022. [Google Scholar]
- 442. Ocrevus. Package insert. Genentech; 2021. [Google Scholar]
- 443. Sandostatin. Package insert. Novartis; 2021. [Google Scholar]
- 444. Sandostatin LAR. Package insert. Novartis; 2021. [Google Scholar]
- 445. Arzerra. Package insert. Novartis; 2016. [Google Scholar]
- 446. Kesimpta. Package insert. Novartis; 2020. [Google Scholar]
- 447. Zyprexa IntraMuscular. Package insert. Eli Lilly; 2021. [Google Scholar]
- 448. Zyprexa Relprevv. Package insert. Eli Lilly; 2021. [Google Scholar]
- 449. Olinvyk. Package insert. Trevena; 2021. [Google Scholar]
- 450. Synribo. Package insert. Teva; 2021. [Google Scholar]
- 451. Xolair. Package insert. Genentech; 2021. [Google Scholar]
- 452. Ondansetron. Package insert. Accord; 2022. [Google Scholar]
- 453. Orphenadrine. Package insert. Akorn; 2019. [Google Scholar]
- 454. Oxaliplatin injection solution. Package insert. Gland Pharma; 2021. [Google Scholar]
- 455. Oxaliplatin lyophilized powder. Package insert. Actavis; 2020. [Google Scholar]
- 456. Abraxane. Package insert. Abraxis BioScience, LLC; 2020. [Google Scholar]
- 457. Paclitaxel. Package insert. Hospira, Inc.; 2021. [Google Scholar]
- 458. Cytalux. Package insert. On Target Laboratories; 2021. [Google Scholar]
- 459. Kepivance. Package insert. Swedish Orphan Biovitrum; 2020. [Google Scholar]
- 460. Palonosetron. Package insert. Cipla USA Inc.; 2022. [Google Scholar]
- 461. Vectibix. Package insert. Amgen Inc.; 2021. [Google Scholar]
- 462. Protonix I.V. Package insert. Wyeth Pharmaceuticals, LLC; 2022. [Google Scholar]
- 463. Papaverine. Package insert. BPI Labs; 2021. [Google Scholar]
- 464. Natpara. Package insert. Shire-NPS Pharmaceuticals, Inc.; 2022. [Google Scholar]
- 465. Signifor. Package insert. Recordati Rare Diseases; 2020. [Google Scholar]
- 466. Oncaspar. Package insert. Servier Pharmaceuticals, LLC; 2021. [Google Scholar]
- 467. Empaveli. Package insert. Apellis Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 468. Fulphila. Package insert. Mylan Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 469. Fylnetra. Package insert. Kashiv BioSciences, LLC; 2022. [Google Scholar]
- 470. Neulasta and Neulasta Onpro. Package insert. Amgen; 2021. [Google Scholar]
- 471. Nyvepria. Package insert. Hospira, Inc.; 2021. [Google Scholar]
- 472. Udenyca. Package insert. Coherus BioSciences, Inc.; 2021. [Google Scholar]
- 473. Ziextenzo. Package insert. Sandoz, Inc.; 2021. [Google Scholar]
- 474. Pegasys. Package insert. Genentech; 2021. [Google Scholar]
- 475. Plegridy. Package insert. Biogen; 2022. [Google Scholar]
- 476. Krystexxa. Package insert. Horizon; 2022. [Google Scholar]
- 477. Palynziq. Package insert. Biomarin Pharmaceuticals; 2020. [Google Scholar]
- 478. Keytruda. Package insert. Merck Sharpe & Dohme; 2022. [Google Scholar]
- 479. Pemetrexed solution for injection. Accord Healthcare, Inc.; 2022. [Google Scholar]
- 480. Pentam. Package insert. Fresenius Kabi USA, LLC; 2019. [Google Scholar]
- 481. Dianeal Low Calcium and Dianeal PD-2. Package insert. Baxter Healthcare Corporation; 2019. [Google Scholar]
- 482. Extraneal. Package insert. Baxter Healthcare Corporation; 2020. [Google Scholar]
- 483. Extraneal and Dianeal. Customized response letter. Baxter Healthcare Corporation; 2022. [Google Scholar]
- 484. Perjeta. Package insert. Genentech, Inc.; 2021. [Google Scholar]
- 485. Phesgo. Package insert. Genentech, Inc.; 2020. [Google Scholar]
- 486. Oraverse. Package insert. Septodont, Inc.; 2017. [Google Scholar]
- 487. Omidria. Package insert. Omeros Corporation; 2017. [Google Scholar]
- 488. Vazculep. Package insert. Exela Phrama Sciences, LLC; 2021. [Google Scholar]
- 489. Phytonadione. Package insert. International Medication Systems, Limited; 2021. [Google Scholar]
- 490. Polivy. Package insert. Genentech, Inc.; 2020. [Google Scholar]
- 491. Varithena. Package insert. Biocompatibles, Inc.; 2021. [Google Scholar]
- 492. IPOL. Package insert. Sanofi Pasteur, Inc.; 2022. [Google Scholar]
- 493. Polymyxin B. Package insert. AuroMedics Pharma, LLC; 2021. [Google Scholar]
- 494. Photofrin. Package insert. Pinnacle Biologics, Inc.; 2021. [Google Scholar]
- 495. Potassium phosphates. Package insert. Fresenius Kabi; 2019. [Google Scholar]
- 496. Jeuveau. Package insert. Evolus, Inc.; 2021. [Google Scholar]
- 497. Folotyn. Package insert. Acrotech Biopharma, LLC; 2020. [Google Scholar]
- 498. Symlin. Package insert. AstraZeneca Pharmaceuticals; 2019. [Google Scholar]
- 499. Citanest Forte Dental. Package insert. Dentsply Pharmaceutical, Inc.; 2020. [Google Scholar]
- 500. Prochlorperazine. Package insert. Nexus Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 501. Phenergan. Package insert. Hikma Pharmaceuticals USA Inc.; 2020. [Google Scholar]
- 502. Propranolol Hydrochloride. Package insert. Fresenius Kabi USA, LLC; 2020. [Google Scholar]
- 503. Ceprotin. Package insert. Baxalta US, Inc.; 2021. [Google Scholar]
- 504. Regonol. Package insert. Sandoz, Inc.; 2021. [Google Scholar]
- 505. Pyridoxine. Package insert. Fresenius Kabi USA, LLC; 2019. [Google Scholar]
- 506. RabAvert. Package insert. GlaxoSmithKline Biologicals; 2019. [Google Scholar]
- 507. Cyramza. Package insert. Eli Lilly and Company; 2022. [Google Scholar]
- 508. Byooviz. Package insert. Biogen Inc.; 2022. [Google Scholar]
- 509. Lucentis. Package insert. Genentech, Inc.; 2018. [Google Scholar]
- 510. Susvimo. Package Insert. Genentech, Inc.; 2022. [Google Scholar]
- 511. Elitek. Package insert. Sanofi-Aventis U.S., LLC; 2019. [Google Scholar]
- 512. Ultomiris. Package insert. Alexion Pharmaceuticals, Inc.; 2022. [Google Scholar]
- 513. Raxibacumab. Package insert. Emergent Manufacturing Operations Baltimore, LLC; 2021. [Google Scholar]
- 514. Byfavo. Package insert. Acacia Pharma, Ltd; 2021. [Google Scholar]
- 515. Cinqair. Package insert. Teva Respiratory, LLC; 2020. [Google Scholar]
- 516. Retavase. Package insert. Chiesi USA, Inc.; 2020. [Google Scholar]
- 517. Rhophylac. Package insert. CSL Behring LLC; 2020. [Google Scholar]
- 518. WinRho SDF. Package insert. Saol Therapeutics Inc.; 2019. [Google Scholar]
- 519. Rifadin. Package insert. Sanofi-Aventis U.S., LLC; 2022. [Google Scholar]
- 520. Arcalyst. Package insert. Kiniksa Pharmaceuticals, Ltd; 2021. [Google Scholar]
- 521. Myobloc. Package insert. Solstice Neurosciences, LLC; 2021. [Google Scholar]
- 522. Skyrizi. Package insert. AbbVie, Inc.; 2022. [Google Scholar]
- 523. Risperdal Consta. Package insert. Janssen Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 524. Riabni. Package insert. Amgen, Inc.; 2022. [Google Scholar]
- 525. Rituxan. Package insert. Genentech, Inc.; 2021. [Google Scholar]
- 526. Ruxience. Package insert. Pfizer Ireland Pharmaceuticals; 2021. [Google Scholar]
- 527. Truxima. Package insert. Cephalon, Inc.; 2022. [Google Scholar]
- 528. Rituxan Hycela. Package insert. Genentech, Inc.; 2021. [Google Scholar]
- 529. Romidepsin. Package insert. Teva Parenteral Medicines, Inc.; 2020. [Google Scholar]
- 530. Nplate. Package insert. Amgen, Inc.; 2022. [Google Scholar]
- 531. Evenity. Package insert. Amgen, Inc.; 2020. [Google Scholar]
- 532. Besremi. Package insert. PharmaEssentia USA Corporation; 2021. [Google Scholar]
- 533. Trodelvy. Package insert. Gilead Sciences; 2022. [Google Scholar]
- 534. Leukine. Package insert. Partner Therapeutics, Inc.; 2022. [Google Scholar]
- 535. Kevzara. Package insert. Sanofi-Aventis U.S., LLC; 2018. [Google Scholar]
- 536. Enspryng. Package insert. Genentech, Inc.; 2021. [Google Scholar]
- 537. Kanuma. Package insert. Alexion Pharmaceuticals, Inc.; 2021. [Google Scholar]
- 538. ChiRhoStim. Package insert. ChiRhoClin, Inc.; 2017. [Google Scholar]
- 539. Cosentyx. Package insert. Novartis Pharmaceuticals Corporation; 2021. [Google Scholar]
- 540. Selenious acid. Package insert. American Regent, Inc.; 2020. [Google Scholar]
- 541. Uptravi. Package insert. Actelion Pharmaceuticals US, Inc.; 2021. [Google Scholar]
- 542. Ozempic. Package insert. Novo Nordisk; 2022. [Google Scholar]
- 543. Wegovy. Package insert. Novo Nordisk; 2021. [Google Scholar]
- 544. Imcivree. Package insert. Rhythm Pharmaceuticals, Inc.; 2022. [Google Scholar]
- 545. Sylvant. Package insert. EUSA Pharma (UK), Ltd; 2019. [Google Scholar]
- 546. Fyarro. Package insert. Aadi Bioscience, Inc.; 2021. [Google Scholar]
- 547. Biolon. Product information. Altacor; 2018. [Google Scholar]
- 548. Euflexxa. Product information. Ferring Pharmaceuticals Inc.; 2016. [Google Scholar]
- 549. Healon Endocoat. Directions for use. Johnson & Johnson Surgical Vision, Inc.; 2019. [Google Scholar]
- 550. Healon GV Pro. Directions for use. Johnson & Johnson Surgical Vision, Inc.; 2020. [Google Scholar]
- 551. Healon Pro. Directions for use. Johnson & Johnson Surgical Vision, Inc.; 2018. [Google Scholar]
- 552. Healon5 Pro. Directions for use. Johnson & Johnson Surgical Vision, Inc.; 2018. [Google Scholar]
- 553. Provisc. Directions for use. Alcon Laboratories, Inc.; 2012. [Google Scholar]
- 554. Gelsyn-3. Product information. Bioventus; 2017. [Google Scholar]
- 555. GenVisc 850. Prescribing information. OrthogenRx, Inc.; 2017. [Google Scholar]
- 556. Hyalgan. Product labeling. Fidia Pharma USA Inc.; 2014. [Google Scholar]
- 557. Triluron. Product information. Fidia Pharma USA Inc.; 2019. [Google Scholar]
- 558. Trivisc. Prescribing information. OrthogenRx, Inc.; 2019. [Google Scholar]
- 559. Revanesse Lips. Instructions for use. Prollenium Medical Technologies; 2020. [Google Scholar]
- 560. Revanesse Versa. Directions for use. Prollenium Medical Technologies; 2020. [Google Scholar]
- 561. Restylane. Instructions for use. Galderma Laboratories, L.P.; 2020. [Google Scholar]
- 562. Restylane Contour. Instructions for use. Galderma Laboratories, L.P.; 2021. [Google Scholar]
- 563. Restylane Defyne. Instructions for use. Galderma Laboratories, L.P.; 2021. [Google Scholar]
- 564. Restylane Kysse. Instructions for use. Galderma Laboratories, L.P.; 2020. [Google Scholar]
- 565. Restylane Lyft with Lidocaine. Instructions for use. Galderma Laboratories, L.P.; 2020. [Google Scholar]
- 566. Restylane Refyne. Instructions for use. Galderma Laboratories, L.P.; 2020. [Google Scholar]
- 567. Restylane Silk. Instructions for use. Galderma Laboratories, L.P.; 2020. [Google Scholar]
- 568. Restylane-L. Instructions for use. Galderma Laboratories, L.P.; 2020. [Google Scholar]
- 569. Sodium Nitrite. Package insert. Hope Pharmaceuticals; 2021. [Google Scholar]
- 570. Nithiodote. Package insert. Hope Pharmaceuticals; 2021. [Google Scholar]
- 571. Nipride RTU. Package insert. Exela Pharma; 2018. [Google Scholar]
- 572. Sodium Thiosulfate. Package insert. Hope Pharmaceuticals; 2020. [Google Scholar]
- 573. Sogroya. Package insert. Novo Nordisk; 2021. [Google Scholar]
- 574. Genotropin. Package insert. Pharmacia and Upjohn Company, LLC; 2019. [Google Scholar]
- 575. Humatrope. Package insert. Eli Lilly and Company; 2019. [Google Scholar]
- 576. Norditropin. Package insert. Novo Nordisk; 2020. [Google Scholar]
- 577. Nutropin AQ Nuspin. Package insert. Genentech, Inc.; 2016. [Google Scholar]
- 578. Omnitrope. Package insert. Sandoz, Inc.; 2019. [Google Scholar]
- 579. Saizen. Package insert. EMD Serono, Inc.; 2020. [Google Scholar]
- 580. Zomacton. Package insert. Ferring Pharmaceuticals, Inc.; 2018. [Google Scholar]
- 581. Sotalol Hydrochloride. Package insert. Altathera Pharmaceuticals, LLC; 2020. [Google Scholar]
- 582. Streptomycin. Package insert. X-GEN Pharmaceuticals, Inc.; 2015. [Google Scholar]
- 583. Zanosar. Package insert. Teva Parenteral Medicines, Inc.; 2021. [Google Scholar]
- 584. Sufentanil Citrate. Package insert. Akorn, Inc.; 2022. [Google Scholar]
- 585. Bridion. Package insert. Merck & Co., Inc.; 2021. [Google Scholar]
- 586. Imitrex injection. Package insert. GlaxoSmithKline, LLC; 2021. [Google Scholar]
- 587. Zembrace SymTouch. Package insert. Upsher-Smith laboratories, LLC; 2021. [Google Scholar]
- 588. Enjaymo. Package insert. Bioverativ USA Inc.; 2022. [Google Scholar]
- 589. Monjuvi. Package insert. MorphoSys US, Inc.; 2021. [Google Scholar]
- 590. Elzonris. Package insert. Stemline Therapeutics, Inc.; 2018. [Google Scholar]
- 591. Elelyso. Package insert. Pfizer, Inc.; 2021. [Google Scholar]
- 592. Imlygic. Package insert. Amgen, Inc.; 2022. [Google Scholar]
- 593. Kimmtrak. Package insert. Immunocore Commercial LLC; 2022. [Google Scholar]
- 594. Neurolite. Package insert. Lantheus Medical Imaging; 2019. [Google Scholar]
- 595. Technescan MAG3. Package insert. Curium US, LLC; 2018. [Google Scholar]
- 596. Myoview. Package insert. GE Healthcare AS; 2022. [Google Scholar]
- 597. Torisel. Package insert. Wyeth Pharmaceuticals, LLC; 2018. [Google Scholar]
- 598. Teniposide. Package insert. WG Critical Care, LLC; 2015. [Google Scholar]
- 599. Tepezza. Package insert. Horizon Therapeutics USA, Inc.; 2021. [Google Scholar]
- 600. Terbutaline. Package insert. Hikma Pharmaceuticals USA, Inc.; 2020. [Google Scholar]
- 601. Forteo. Package insert. Eli Lilly and Company; 2021. [Google Scholar]
- 602. Egrifta SV. Package insert. Theratechnologies, Inc.; 2019. [Google Scholar]
- 603. Depo-Testosterone. Package insert. Pharmacia and Upjohn Company, LLC; 2018. [Google Scholar]
- 604. Xyosted. Package insert. Antares Pharma, Inc.; 2019. [Google Scholar]
- 605. Tetracaine. Package insert. BPI Labs, LLC; 2020. [Google Scholar]
- 606. Tezspire. Package insert. Amgen Inc.; 2021. [Google Scholar]
- 607. Thiamine. Package insert. Mylan Institutional, LLC; 2021. [Google Scholar]
- 608. Thiotepa. Package insert. Hikma Pharmaceuticals USA, Inc.; 2019. [Google Scholar]
- 609. Thyrogen. Package insert. Genzyme Corporation; 2020. [Google Scholar]
- 610. Ilumya. Package insert. Sun Pharmaceutical Industries, Inc.; 2021. [Google Scholar]
- 611. Aggrastat. Package insert. Medicure International, Inc.; 2020. [Google Scholar]
- 612. Mounjaro. Package insert. Lilly USA, LLC; 2022. [Google Scholar]
- 613. Tivdak. Package insert. Seagen, Inc.; 2021. [Google Scholar]
- 614. Actemra. Package insert. Genentech, Inc.; 2022. [Google Scholar]
- 615. Hycamtin. Package insert. Novartis Pharmaceuticals Corporation; 2019. [Google Scholar]
- 616. Topotecan. Package insert. Mylan Institutional, LLC; 2020. [Google Scholar]
- 617. Adbry. Package insert. LEO Pharma Inc.; 2022. [Google Scholar]
- 618. Herceptin Hylecta. Package insert. Genentech, Inc.; 2019. [Google Scholar]
- 619. Kanjinti. Package insert. Amgen, Inc.; 2019. [Google Scholar]
- 620. Trazimera. Package insert. Pfizer Ireland Pharmaceuticals; 2020. [Google Scholar]
- 621. Enhertu. Package insert. Daiichi Sankyo, Inc.; 2021. [Google Scholar]
- 622. Triesence. Package insert. Alcon Laboratories, Inc.; 2016. [Google Scholar]
- 623. Xipere. Package insert. Bausch & Lomb Americas Inc.; 2022. [Google Scholar]
- 624. Kenalog-10. Package insert. Bristol-Myers Squibb Company; 2018. [Google Scholar]
- 625. Kenalog-40. Package insert. Bristol-Myers Squibb Company; 2019. [Google Scholar]
- 626. Kenalog-80. Package insert. Bristol-Myers Squibb Company; 2019. [Google Scholar]
- 627. VisionBlue. Package insert. Dutch Ophthalmic Research Center (International) B.V.; 2012. [Google Scholar]
- 628. Aplisol. Package insert. Par Pharmaceutical, Inc.; 2016. [Google Scholar]
- 629. Tubersol. Package insert. Sanofi Pasteur, Inc.; 2021. [Google Scholar]
- 630. Stelara. Package insert. Janssen Biotech, Inc.; 2020. [Google Scholar]
- 631. Varivax. Package insert. Merck Sharp & Dohme Corp.; 2021. [Google Scholar]
- 632. Shingrix. Package insert. GlaxoSmithKline Biologicals SA; 2021. [Google Scholar]
- 633. Zostavax. Package insert. Merck Sharp & Dohme Corp.; 2019. [Google Scholar]
- 634. Vecuronium. Package insert. AuroMedics Pharma, LLC; 2021. [Google Scholar]
- 635. Entyvio. Package insert. Takeda Pharmaceuticals America, Inc.; 2022. [Google Scholar]
- 636. Vpriv. Package insert. Takeda Pharmaceuticals America, Inc.; 2021. [Google Scholar]
- 637. Verapamil. Package insert. AuroMedics Pharma, LLC; 2021. [Google Scholar]
- 638. Visudyne. Package insert. Bausch Health US, LLC; 2021. [Google Scholar]
- 639. Mepsevii. Package insert. Ultragenyx Pharmaceutical, Inc.; 2020. [Google Scholar]
- 640. Vinblastine. Package insert. Fresenius Kabi USA, LLC; 2016. [Google Scholar]
- 641. Vincristine. Package insert. Hospira, Inc.; 2021. [Google Scholar]
- 642. Vinorelbine. Package insert. Sagent Pharmaceuticals; 2020. [Google Scholar]
- 643. Aquasol A. Package insert. Casper Pharma, LLC; 2019. [Google Scholar]
- 644. Wilate. Package insert. Octapharma USA, Inc.; 2019. [Google Scholar]
- 645. Voxzogo. Package insert. BioMarin Pharmaceutical Inc.; 2021. [Google Scholar]
- 646. Prialt. Package insert. TerSera Therapeutics, LLC; 2019. [Google Scholar]
- 647. Retrovir. Package insert. ViiV Healthcare Company; 2020. [Google Scholar]
- 648. Zinc sulfate. Package insert. American Regent, Inc.; 2020. [Google Scholar]
- 649. Geodon. Package insert. Pfizer, Inc.; 2021. [Google Scholar]